<SEC-DOCUMENT>0000921895-24-000862.txt : 20240417
<SEC-HEADER>0000921895-24-000862.hdr.sgml : 20240417
<ACCEPTANCE-DATETIME>20240417160323
ACCESSION NUMBER:		0000921895-24-000862
CONFORMED SUBMISSION TYPE:	PREC14A
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20240417
DATE AS OF CHANGE:		20240417

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WisdomTree, Inc.
		CENTRAL INDEX KEY:			0000880631
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		ORGANIZATION NAME:           	02 Finance
		IRS NUMBER:				133487784
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PREC14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10932
		FILM NUMBER:		24850965

	BUSINESS ADDRESS:	
		STREET 1:		250 WEST 34TH STREET
		STREET 2:		3RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10119
		BUSINESS PHONE:		212-801-2080

	MAIL ADDRESS:	
		STREET 1:		250 WEST 34TH STREET
		STREET 2:		3RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10119

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WisdomTree Investments, Inc.
		DATE OF NAME CHANGE:	20090401

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INDEX DEVELOPMENT PARTNERS INC
		DATE OF NAME CHANGE:	20020812

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FINANCIAL DATA SYSTEMS
		DATE OF NAME CHANGE:	19951120

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ETFS Capital Limited.
		CENTRAL INDEX KEY:			0001520619
		STANDARD INDUSTRIAL CLASSIFICATION:	 [6221]
		ORGANIZATION NAME:           	09 Crypto Assets
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		PREC14A

	BUSINESS ADDRESS:	
		STREET 1:		Ordnance House
		STREET 2:		31 Pier Road
		CITY:			St. Helier, Channel Islands
		STATE:			Y9
		ZIP:			JE4 8PW
		BUSINESS PHONE:		44-153--482-5500

	MAIL ADDRESS:	
		STREET 1:		Ordnance House
		STREET 2:		31 Pier Road
		CITY:			St. Helier, Channel Islands
		STATE:			Y9
		ZIP:			JE4 8PW

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ETF Securities Ltd
		DATE OF NAME CHANGE:	20110512
</SEC-HEADER>
<DOCUMENT>
<TYPE>PREC14A
<SEQUENCE>1
<FILENAME>prec14a13246002_04152024.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
14A</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Rule
14a-101)</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">INFORMATION REQUIRED IN PROXY STATEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">SCHEDULE 14A INFORMATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Amendment No. )</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Filed by the Registrant &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Filed by a Party other than the Registrant &#9746;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Check the appropriate box:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9746;</TD><TD>Preliminary Proxy Statement</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9744;</TD><TD>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9744;</TD><TD>Definitive Proxy Statement</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9744;</TD><TD>Definitive Additional Materials</TD></TR></TABLE>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9744;</TD><TD>Soliciting Material Under &sect; 240.14a-12</TD></TR></TABLE>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 100%; text-align: center; vertical-align: top; border-bottom: Black 0.5pt solid">WISDOMTREE, INC.</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="text-align: center; vertical-align: top"><P>(Name of Registrant as Specified In Its Charter)</P>

</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="text-align: center; vertical-align: top; border-bottom: Black 0.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase">ETFS CAPITAL
LIMITED</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="text-transform: uppercase">GRAHAM TUCKWELL</FONT></P>
</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="text-align: center; vertical-align: top"><P>(Name of Persons(s) Filing Proxy Statement, if other than the Registrant)</P>

</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Payment of Filing Fee (Check all boxes that apply):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9746;</TD><TD>No fee required</TD></TR></TABLE>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9744;</TD><TD>Fee paid previously with preliminary materials</TD></TR></TABLE>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9744;</TD><TD>Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11</TD></TR></TABLE>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="color: red"><B>PRELIMINARY COPY
SUBJECT TO COMPLETION<BR>
DATED APRIL 17, 2024</B></FONT><B><BR>
<BR>
ETFS CAPITAL LIMITED<BR>
<BR>
___________________, 2024</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Dear Fellow WisdomTree Stockholders:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">ETFS Capital Limited and
the other participants in this solicitation (collectively, &ldquo;ETFS,&rdquo; &ldquo;we&rdquo; or &ldquo;our&rdquo;) are the beneficial
owners of an aggregate of 15,250,000 shares of common stock, par value $0.01 per share (the &ldquo;Common Stock&rdquo;), of WisdomTree,
Inc., a Delaware corporation (&ldquo;WisdomTree&rdquo; or the &ldquo;Company&rdquo;), representing approximately 10.0% of the outstanding
shares of Common Stock. For the reasons set forth in the attached Proxy Statement, we believe that immediate action is required by the
Company to unlock significant value for all stockholders and stop any further value destruction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We believe there is significant
value to be unlocked within the Company&rsquo;s shares. As a long-term stockholder of the Company, with deep ETF industry and operating
expertise, we have attempted to constructively engage with the Company&rsquo;s Board of Directors (the &ldquo;Board&rdquo;) both before
and after the Company&rsquo;s 2023 Annual Meeting of Stockholders regarding the Company&rsquo;s long-term destruction of stockholder value,
excessive cost-structure, negligent capital allocation, and the consistent inability to keep the best interest of stockholders in mind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">A prime example of the
Company&rsquo;s shortcomings is the ill-advised strategy of trying to transform the Company from an ETF business to a decentralized finance
(&ldquo;DeFi&rdquo;) business over the past several years, which has resulted in the core ETF business being poorly managed. Moreover,
all of the Company&rsquo;s DeFi efforts continue to flounder. Specifically, the Company&rsquo;s flagship DeFi initiatives, namely WisdomTree
Prime (&ldquo;WT Prime&rdquo;), which was launched in July of 2023, and the Company&rsquo;s Bitcoin ETF, which was launched in January
of 2024, have been unsuccessful in generating any meaningful market interest, and have diverted management&rsquo;s attention from the
Company&rsquo;s principal ETF business, where we believe the true value of WisdomTree lies. In our view, WT Prime is and always has been
a complete folly, and in crypto ETFs, the Company continues to rank towards the bottom relative to its peers. The result of this misguided
 &lsquo;transformation&rsquo; strategy is that, despite record assets under management, WisdomTree&rsquo;s traditional ETF business continues
to suffer from poor profitability. Consequently, we believe WisdomTree trades at a significant discount to its intrinsic value if it were
a well-run pure-play ETF business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">In the hope of having a
collaborative and productive dialogue, we attempted to engage privately with the Board on the actions required to close the value gap
and enhance stockholder value. To that end, we met with members of the Board on February 13, 2024, and on February 20, 2024, we wrote
a letter to the Board, in which we acknowledged that individual members of the Board and stockholders have divergent views about the best
way forward to unlock value at WisdomTree. We proposed that the Board form a special committee of independent directors with a mandate
to consider strategic alternatives including, but not limited to, a sale of part or all of the business and returning capital to stockholders,
as well as a significant repositioning of the business, including replacing certain members of WisdomTree&rsquo;s senior leadership team.
We further proposed that the special committee retain a recognized tier-one investment bank along with independent counsel to assist with
this review of strategic alternatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Unfortunately, rather than
genuinely engage with one of its largest stockholders, the Company decided to respond to our private proposal with a public and bafflingly
hostile response. However, this did not come as a surprise to us. Over the past several years, we have attempted to address operational
and governance shortcomings at the Company through a myriad of ways, including by writing public and private letters to the Board, discussing
our ideas with members of senior management and by running full proxy campaigns. Unfortunately, the resulting change to the Board has
been insufficient to overcome the pervasive influence that management and long-tenured directors exert in maintaining the status quo.</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We believe that stockholders
must send a strong message to the Board that they do not approve of the Company&rsquo;s current trajectory or the Board&rsquo;s stewardship
and oversight of management and the Company, and that the Board must take the necessary steps for the Company&rsquo;s stockholders to
realize the maximum value of their investments and hold management accountable. For the reasons set forth above, we intend to vote <B>AGAINST
</B>the election of [__], [__] and [__] at the Company&rsquo;s upcoming annual meeting of stockholders as a referendum on the Company&rsquo;s
ill-advised transformation strategy and its refusal to unlock value through a strategic review process and we urge other stockholders
to do the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">It is time to send a clear
and resounding signal to the Board &ndash; stockholders will not accept the status quo, hire a reputable banker and evaluate all options
to unlock value as soon as possible. We urge Board members to reconsider their decision and act as independent fiduciaries for all stockholders
 &ndash; the true owners of WisdomTree.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Accordingly, we are urging
you to vote <B>AGAINST</B> the election of [__], [__] and [__] as directors at the Company&rsquo;s upcoming annual meeting of stockholders.
By voting <B>AGAINST</B> the election of [__], [__] and [__], stockholders will be sending a strong message to the Board that they are
dissatisfied with the status quo and that meaningful change is required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We note that the election
of directors at WisdomTree requires the affirmative vote of a majority of the votes cast in uncontested elections. <B>Importantly, the
Company has a director resignation policy in place for uncontested elections, whereby <FONT STYLE="background-color: white">an incumbent
director who is not re-elected shall tender his or her resignation to the Board</FONT>. </B><FONT STYLE="background-color: white">The
Nominating and Governance Committee of the Board will make a recommendation to the Board on whether to accept or reject the resignation,
or whether other action should be taken. The Board will act on the recommendation of such committee and will publicly disclose its decision
within 90 days from the date of the certification of the election results. If our proxy solicitation results in any directors failing
to receive a majority of the votes cast for his or her election, then we believe it would clearly be inappropriate for any such director
to continue to serve on the Board. We believe the failure of the Board to accept any such tendered resignations that may result from the
Company&rsquo;s upcoming annual meeting of stockholders would be an egregious violation of proper corporate governance, and in direct
opposition to a clear stockholder directive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We urge you to carefully
consider the information contained in the attached Proxy Statement and then support our efforts by signing, dating and returning the enclosed
<B>GOLD</B> proxy card today. The attached Proxy Statement and the enclosed <B>GOLD</B> proxy card are first being furnished to stockholders
on or about ______, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">If you have already voted
for the incumbent management slate, you have every right to change your vote by signing, dating and returning a later dated <B>GOLD</B>
proxy card or by voting virtually at the upcoming annual meeting of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">If you have any questions
or require any assistance with your vote, please contact Saratoga Proxy Consulting LLC, which is assisting us, at its address and toll-free
numbers listed below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 3.5in">Thank you for your support,<BR>
<BR>
/s/ Graham Tuckwell<BR>
Graham Tuckwell<BR>
ETFS Capital Limited</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 3.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; border: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>If you have any questions, require assistance in
    voting your <B>GOLD</B> proxy card,</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>or need additional copies of ETFS&rsquo; proxy materials,</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>please contact Saratoga at the phone numbers listed
    below.</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="image_001.jpg" ALT="Saratoga Proxy Consulting LLC" STYLE="height: 83px; width: 317px"></P>
    <P STYLE="font: 10pt Franklin Gothic Book,sans-serif; margin: 0; text-align: center"><B>520 8<SUP>th</SUP> Avenue, 14<SUP>th</SUP> Floor</B></P>
    <P STYLE="font: 10pt Franklin Gothic Book,sans-serif; margin: 0; text-align: center"><B>New York, NY 10018</B></P>
    <P STYLE="font: 10pt Franklin Gothic Book,sans-serif; margin: 0; text-align: center"><B>(212) 257-1311</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 1.25in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><I>Stockholders call toll free at (888) 368-0379<BR>
    Email: <FONT STYLE="color: #0563C1">info@saratogaproxy.com</FONT></I></B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="color: red"><B>PRELIMINARY COPY
SUBJECT TO COMPLETION<BR>
DATED APRIL 17, 2024 </B></FONT><B><BR>
<BR>
2024 ANNUAL MEETING OF STOCKHOLDERS<BR>
OF<BR>
WISDOMTREE, INC.<BR>
_________________________<BR>
<BR>
PROXY STATEMENT<BR>
OF<BR>
ETFS CAPITAL LIMITED<BR>
_________________________<BR>
<BR>
PLEASE SIGN, DATE AND MAIL THE ENCLOSED GOLD PROXY CARD TODAY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">ETFS Capital Limited, a
Jersey company (&ldquo;ETFS Capital&rdquo;), and the other participant in this solicitation (collectively, &ldquo;ETFS,&rdquo; &ldquo;we&rdquo;
or &ldquo;our&rdquo;) are significant stockholders of WisdomTree, Inc., a Delaware corporation (&ldquo;WisdomTree&rdquo; or the &ldquo;Company&rdquo;),
who beneficially own an aggregate of 15,250,000 shares of common stock, par value $0.01 per share (the &ldquo;Common Stock&rdquo;), of
WisdomTree, representing approximately 10.0% of the outstanding shares of Common Stock. We believe that stockholders must send a strong
message to the Company&rsquo;s Board of Directors (the &ldquo;Board&rdquo;) that they do not approve of the Company&rsquo;s current trajectory
or the Board&rsquo;s stewardship and oversight of the Company, and that the Board must take the necessary steps for the Company&rsquo;s
stockholders to realize the maximum value of their investments and conduct a comprehensive strategic review process. To that end, we are
seeking your support at the Company&rsquo;s 2024 annual meeting of stockholders scheduled to be held virtually at www.virtualshareholdermeeting.com/[&bull;]
on [____], 2024 at [_:__] (including any adjournments or postponements thereof and any meeting which may be called in lieu thereof, the
 &ldquo;2024 Annual Meeting&rdquo;) to vote <B>AGAINST </B>the election of [__], [__] and [__], to the Board. This Proxy Statement and
the enclosed <B>GOLD</B> proxy card are first being mailed to stockholders on or about [____________], 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In addition, our <B>GOLD</B> proxy
card will also allow stockholders to vote on the following proposals that are being presented by the Company for stockholder consideration
at the 2024 Annual Meeting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify">The ratification of the appointment of Ernst &amp; Young LLP as the Company&rsquo;s independent registered
public accounting firm for the fiscal year ending December 31, 2024;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify">An advisory resolution to approve the compensation of the Company&rsquo;s named executive officers;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify">A non-binding, advisory vote on the frequency of future advisory votes to approve the compensation of
the Company&rsquo;s named executive officers; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify">The ratification of the approval by the Board of the extension of the Stockholder Rights Agreement, dated
March 17, 2023, as amended (the &ldquo;Poison Pill&rdquo;), by and between the Company and Continental Stock Transfer &amp; Trust Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Stockholders may also transact
such other business as may properly come before the 2024 Annual Meeting.</P>

<!-- Field: Page; Sequence: 5; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The Company has disclosed
that the 2024 Annual Meeting will be conducted virtually over the Internet. Stockholders will not be able to attend the 2024 Annual Meeting
in person. In order to attend the 2024 Annual Meeting online and submit written questions during the 2024 Annual Meeting, you must register
in advance by visiting www.virtualshareholdermeeting.com/[&bull;]. For further information on how to attend and vote virtually at the
2024 Annual Meeting and by proxy, please see the &ldquo;VOTING AND PROXY PROCEDURES&rdquo; and &ldquo;ATTENDING THE 2024 ANNUAL MEETING
VIRTUALLY ON THE INTERNET&rdquo; sections of this Proxy Statement below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">As of the date hereof,
ETFS Capital and Graham Tuckwell (each a &ldquo;Participant&rdquo;), own 15,250,000 shares of Common Stock (the &ldquo;ETFS Shares&rdquo;),
as well as 14,750 shares of Series A Non-Voting Convertible Preferred Stock (the &ldquo;Series A Preferred Stock&rdquo;), which are convertible
into 14,750,000 shares of Common Stock, subject to certain limitations. We intend to vote the ETFS Shares <B>AGAINST</B> the election
of [__], [__] and [__] <FONT STYLE="background-color: white">and <B>FOR</B></FONT> the election of the remaining Company director nominees
up for election (collectively, the &ldquo;Company Nominees&rdquo;) at the 2024 Annual Meeting, <B>FOR</B> the ratification of the appointment
of Ernst &amp; Young LLP as the Company&rsquo;s independent registered public accounting firm for the fiscal year ending December 31,
2024, <B>AGAINST</B> approval of the advisory vote on the compensation of the Company&rsquo;s named executive officers, <B>ONE YEAR</B>
on the vote on the frequency of future advisory votes to approve the compensation of the Company&rsquo;s named executive officers, and
<B>AGAINST</B> the ratification of the Board&rsquo;s approval of the extension of the Poison Pill.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Please note that the Company
Nominees are not the nominees of ETFS, and, accordingly, they are not participants in this solicitation. We can provide no assurance that
any of the Company Nominees will serve as directors if elected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The Company has set the
close of business on [_______], 2024 as the record date for determining stockholders entitled to notice of and to vote at the 2024 Annual
Meeting (the &ldquo;Record Date&rdquo;). The mailing address of the principal executive offices of the Company is 250 West 34<SUP>th</SUP>
Street, 3<SUP>rd</SUP> Floor, New York, NY 10119. Stockholders of record at the close of business on the Record Date will be entitled
to vote at the 2024 Annual Meeting. According to the Company, as of the Record Date, there were [_______] shares of Common Stock outstanding
and entitled to vote at the 2024 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We urge you to carefully
consider the information contained in this Proxy Statement and then support our efforts by signing, dating and returning the enclosed
<B>GOLD</B> proxy card today.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">THIS SOLICITATION IS BEING
MADE BY ETFS AND NOT ON BEHALF OF THE BOARD OR MANAGEMENT OF THE COMPANY. WE ARE NOT AWARE OF ANY OTHER MATTERS TO BE BROUGHT BEFORE THE
2024 ANNUAL MEETING OTHER THAN AS SET FORTH IN THIS PROXY STATEMENT. SHOULD OTHER MATTERS, WHICH ETFS IS NOT AWARE OF A REASONABLE TIME
BEFORE THIS SOLICITATION, BE BROUGHT BEFORE THE 2024 ANNUAL MEETING, THE PERSONS NAMED AS PROXIES IN THE ENCLOSED <B>GOLD </B>PROXY CARD
WILL VOTE ON SUCH MATTERS IN THEIR DISCRETION.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">ETFS URGES YOU TO SIGN,
DATE AND RETURN THE <B>GOLD </B>PROXY CARD TO VOTE <B>AGAINST</B> THE ELECTION OF <B>[__], [__] AND [__]</B> TO THE BOARD AT THE 2024
ANNUAL MEETING.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">IF YOU HAVE ALREADY SENT
A PROXY CARD FURNISHED BY COMPANY MANAGEMENT OR THE BOARD, YOU MAY REVOKE THAT PROXY AND VOTE ON EACH OF THE PROPOSALS DESCRIBED IN THIS
PROXY STATEMENT BY SIGNING, DATING AND RETURNING THE ENCLOSED <B>GOLD </B>PROXY CARD. THE LATEST DATED PROXY IS THE ONLY ONE THAT COUNTS.
ANY PROXY MAY BE REVOKED AT ANY TIME PRIOR TO THE 2024 ANNUAL MEETING BY DELIVERING A WRITTEN NOTICE OF REVOCATION OR A LATER DATED PROXY
FOR THE 2024 ANNUAL MEETING OR BY VOTING VIRTUALLY AT THE 2024 ANNUAL MEETING.</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>Important Notice Regarding the Availability
of Proxy Materials for the 2024 Annual Meeting&mdash;This Proxy Statement and our <U>GOLD</U> proxy card are available at </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>www.[_____________________].com</B></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B><FONT STYLE="background-color: yellow"><BR>
</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>IMPORTANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>Your vote is important,
no matter how few shares of Common Stock you own. ETFS urges you to sign, date, and return the enclosed <U>GOLD</U> proxy card today to
vote &ldquo;AGAINST&rdquo; the election of [__], [__] and [__] to the Board and in accordance with ETFS&rsquo; recommendations on the
other proposals on the agenda for the 2024 Annual Meeting.</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">If your shares of Common Stock are registered in your own name, please sign and date the enclosed <B>GOLD
</B>proxy card and return it to ETFS, c/o Saratoga Proxy Consulting LLC (&#8220;Saratoga&#8221;), in the enclosed postage-paid envelope
today. Stockholders also have the following two options for authorizing a proxy to vote shares registered in their name:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Courier New, Courier, Monospace">o</FONT></TD><TD STYLE="text-align: justify">Via the Internet at [______] at any time prior to 11:59 p.m. (Eastern Time) on the day before the 2024
Annual Meeting, and follow the instructions provided on the <B>GOLD </B>proxy card; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Courier New, Courier, Monospace">o</FONT></TD><TD STYLE="text-align: justify">By telephone, by calling [______] at any time prior to 11:59 p.m. (Eastern Time) on the day before the
2024 Annual Meeting, and follow the instructions provided on the <B>GOLD </B>proxy card.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">If your shares of Common Stock are held in a brokerage account or bank, you are considered the beneficial
owner of the shares of Common Stock, and these proxy materials, together with a <B>GOLD</B> voting instruction form, are being forwarded
to you by your broker or bank. As a beneficial owner, if you wish to vote, you must instruct your broker, trustee or other representative
how to vote. Your broker cannot vote your shares of Common Stock on your behalf without your instructions.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">Depending upon your broker or custodian, you may be able to vote either by toll-free telephone or by the
Internet. Please refer to the enclosed voting instruction form for instructions on how to vote electronically. You may also vote by signing,
dating and returning the enclosed voting instruction form.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You may vote your shares virtually at the 2024 Annual Meeting. Even if you plan to attend the 2024 Annual
Meeting virtually, we recommend that you submit your <B>GOLD</B> proxy card by mail, internet or telephone by the applicable deadline
so that your vote will be counted if you later decide not to attend the 2024 Annual Meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Since only your latest
dated proxy card will count, we urge you not to return any proxy card you receive from the Company, as it will revoke any proxy card you
may have previously sent to us. So please make sure that the latest dated proxy card you return is the <B>GOLD </B>proxy card.</P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; border: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>If you have any questions, require assistance in
    voting your <B>GOLD</B> proxy card,</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>or need additional copies of ETFS&rsquo; proxy materials,</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>please contact Saratoga at the phone numbers listed
    below.</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="image_002.jpg" ALT="Saratoga Proxy Consulting LLC" STYLE="height: 83px; width: 317px"></P>
    <P STYLE="font: 10pt Franklin Gothic Book,sans-serif; margin: 0; text-align: center"><B>520 8<SUP>th</SUP> Avenue, 14<SUP>th</SUP> Floor</B></P>
    <P STYLE="font: 10pt Franklin Gothic Book,sans-serif; margin: 0; text-align: center"><B>New York, NY 10018</B></P>
    <P STYLE="font: 10pt Franklin Gothic Book,sans-serif; margin: 0; text-align: center"><B>(212) 257-1311</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 1.25in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><I>Stockholders call toll free at (888) 368-0379<BR>
    Email: <FONT STYLE="color: #0563C1">info@saratogaproxy.com</FONT></I></B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>BACKGROUND TO THE SOLICITATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">The following is a chronology of material events
leading up to this proxy solicitation:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">On June 16, 2023, the Company held its 2023 annual meeting of stockholders (the &#8220;2023 Annual Meeting&#8221;).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">On
October 12, 2023, Mr. Tuckwell emailed the Chairman of the Board, Win Neuger, requesting a meeting with the Board in person in New York
the following month. Mr. Neuger respond to Mr. Tuckwell and offered a video meeting with the Board.&nbsp;</P></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">On November 14, 2023, Mr. Tuckwell and other representatives from ETFS
met with various members of the Board and management in a video call. On the video call, Mr. Tuckwell expressed his concern that the Company
does not appear to be interested in having a two-way dialogue with ETFS. Mr. Tuckwell stated that ETFS had given the Board quite a lot
of detailed information and suggestions regarding the Company and how to improve the Company in two presentations last year but had received
no feedback to date. Mr. Tuckwell expressed his view that ETFS was politely listened to but completely ignored by the Board. Although
some two-way discussion did follow regrading some aspects of the Company&rsquo;s business and strategy, the Company did not commit to
taking any steps to effect any of the changes suggested by ETFS nor was there any written follow-up by the Company regarding the matters
discussed.</P></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">On February 13, 2024, Mr. Tuckwell met with certain members of the Board, Win Neuger and Tonia Pankopf.
At the meeting, Mr. Tuckwell explained his concerns that since mid-2018 the Company&#8217;s assets under management (&#8220;AUM&#8221;)
had almost doubled but the share price had remained stagnant because of poor management. To restore value to stockholders, Mr. Tuckwell
discussed a number of proposals which he requested the Board consider, as discussed in the bullet below.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">On February 20, 2024, ETFS sent a private letter to Mr. Neuger and Ms. Pankopf following up on their February
13, 2024 meeting. In the letter, ETFS expressed their disappointment with the Company&#8217;s execution of its strategy and performance
and highlighted the Company&#8217;s underperformance as compared to relevant peers and indices over the last 5-year and 10-year periods,
and since the Company&#8217;s acquisition of ETFS&#8217; successful ETC business in 2018. ETFS requested that the Board consider three
proposals: (i) replacing the Company&#8217;s CEO with someone who can add and not destroy value; (ii) raising outside money for WisdomTree
Prime (&#8220;WT Prime&#8221;) rather than wasting stockholder money on it; and (iii) appointing a reputable investment bank to review
strategic alternatives for the Company. In the letter, ETFS also proposed that, at a minimum, (a) a special committee of the Board consisting
of independent directors should be formed and the Company should publicly announce that it will run a strategic review process of the
entire business, (b) the special committee should retain an independent financial advisor from a recognized tier-one investment bank and
retain independent counsel, and (c) the special committee should be given a mandate to consider various strategic alternatives for WisdomTree,
including, but not limited to, a sale of part or all of the business, returning capital to stockholders, and a significant repositioning
of the business, including the replacement of members of the Company&#8217;s senior leadership team.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>


<P STYLE="margin-top: 0; margin-bottom: 0"></P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">On February 27, 2024, the Company issued a public letter to ETFS in response to ETFS&#8217; private letter
to the Board. In this letter, the Board stated that, after reviewing ETFS&#8217; proposals, it concluded not to implement any of them
because the Board believed taking any of these actions would undermine the Company&#8217;s long-term growth strategy and value-creation
initiatives for the reasons set forth therein. The letter, among other things, also highlighted the Company&#8217;s engagement with ETFS
over the prior two years, discussed the Company&#8217;s corporate governance practices, and claimed that the Company has a track record
of delivering value to stockholders and that it has a clear and compelling strategy for the future.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">On March 18, 2024, the Company announced it was extending the expiration
of its Poison Pill to March 17, 2025, provided that if stockholders did not ratify the Board&rsquo;s approval of the extension of the
Poison Pill at the 2024 Annual Meeting, then the Poison Pill would expire by the close of business on the first day after the 2024 Annual
Meeting.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">On March 21, 2024, ETFS issued a public letter to stockholders in response to the Company&#8217;s unconventional
public response to Mr. Tuckwell&#8217;s private communications to the Board. In this letter, ETFS discussed its attempts to constructively
engage with the Company both recently and over the prior three years, its concerns with the Company&#8217;s ill-advised strategy of trying
to transform the Company from an ETF business to a DeFi business, and its belief that further change to the Board is required to break
the status quo.</TD></TR></TABLE>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">On April 12, 2024, the Company filed its preliminary proxy statement with the SEC in connection with the
2024 Annual Meeting.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">On April 17, 2024, ETFS filed its preliminary proxy statement with the SEC in connection with the 2024
Annual Meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>REASONS FOR THE SOLICITATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>WE BELIEVE THAT IMMEDIATE ACTION IS REQUIRED
BY THE BOARD TO UNLOCK SIGNIFICANT VALUE FOR ALL STOCKHOLDERS BY INITIATING A STRATEGIC REVIEW OF WISDOMTREE&rsquo;S CORE ETF BUSINESS
AND ITS DEFI BUSINESSES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-right: 0; margin-left: 0">For many
years now WisdomTree has embarked on an ill-advised strategy of trying to transform the Company from an ETF business to a DeFi business,
which has resulted in the core ETF business being poorly managed whilst the Company&rsquo;s DeFi efforts have floundered. After years
of attempting to constructively engage with the Company, it is clear to us that the Board is incapable of acknowledging the value destruction
caused by this ill-advised strategy and of accepting that a change of strategy is urgently needed to restore and unlock the true value
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-right: 0; margin-left: 0">We strongly
believe change is needed and we ask that you vote with us to precipitate that change. We are voting to tell the Board they must appoint
an independent financial advisor to examine strategic alternatives, including casting a critical eye over the Company&rsquo;s existing
strategy. We believe any qualified and independent financial advisor will conclude that there is substantial value to be unlocked, as
detailed below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-right: 0; margin-left: 0">The way
to vote for this change is to follow ETFS&rsquo; voting recommendation and to vote <B>AGAINST</B> the re-election of the following director
nominees, [__], [__] and [__]. A stockholder majority vote against the re-election of [__], [__] and [__] will be a clear and unequivocal
message to the Board that they must appoint an independent financial advisor to examine strategic alternatives.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-right: 0; margin-left: 0">To be clear,
we are not seeking to take over the Company or nominate individuals for election to the Board, but rather to compel the current Board
to restore value for all stockholders. We have a track record of building and running impressive ETF businesses around the world, and
we know what good looks like. We also know what bad looks like and there is much of that embedded in the WisdomTree management strategy
and Board oversight of such in our view.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-left: 0"><B>No Amount of Bluster by the
Company can Paper Over the Following Compelling Conclusions which the Board Refuses to Acknowledge</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Based on our substantial
ETF industry expertise (and more recent investments in DeFi), it is clear to us that:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 21.3pt">1)</TD><TD STYLE="text-align: justify">WisdomTree trades at a significant discount to its intrinsic value if it were a well-run pure-play ETF
business. We also believe that <B><I>WisdomTree&rsquo;s current valuation represents a significant discount to what its ETF business could
be worth to a strategic investor</I></B>.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 21.3pt">2)</TD><TD STYLE="text-align: justify"><B><I>The core ETF business has been poorly managed</I></B>, as measured by the following ETF industry
metrics:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 21.25pt"><FONT STYLE="font-family: Wingdings">&#216;</FONT></TD><TD STYLE="text-align: justify">The operating margin for a well-run ETF business should be around 40% to 45% rather than the 27% for the
Company (based on 2023 annual figures removing contractual Gold payments).<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>1</SUP></FONT>
So the Company appears to be wasting around 15% of its revenues on unnecessary expenses. With the Company&rsquo;s global ETF revenues
running at $389 million per annum,<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>2</SUP></FONT> that means WisdomTree
could reduce its expenses by $58 million per annum which, at a tax rate of 25% and a PE multiple of 14x, would translate into an additional
$613 million of stockholder value.<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>3</SUP></FONT></TD></TR></TABLE>

<HR ALIGN="LEFT" SIZE="1" STYLE="width: 33%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>1</SUP></FONT>
Company 2023 Annual Report on Form 10-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>2</SUP></FONT>
Run rate revenues as of March 31, 2024 calculated using WisdomTree data on the Company&rsquo;s website.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>3
</SUP></FONT>Assumed global tax rate of 25% as disclosed in the Company&rsquo;s 2023 Annual Report on Form 10-K. PE multiple based on
LTM earnings as of April 16, 2024. Factset.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-right: 0; margin-left: 0"></P>



<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 21.25pt"><FONT STYLE="font-family: Wingdings">&#216;</FONT></TD><TD STYLE="text-align: justify">WisdomTree has lost significant ETF market share in the US compared to its main competitors (being ProShares,
Van Eck and Global X). When WisdomTree was still focused on its core ETF business (six years ago), it had approximately 37% of the market
share amongst those four, but that has now declined to approximately 28%.<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>4</SUP></FONT>
Had WisdomTree maintained its market share, it would have an extra $23 billion of AUM<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>5</SUP></FONT>
and an extra $412 million of stockholder value.<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>6</SUP></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 21.25pt"><FONT STYLE="font-family: Wingdings">&#216;</FONT></TD><TD STYLE="text-align: justify">The combined loss in value from the above two items is $1,025 million, all caused by poor management of
the core ETF business.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 21.3pt"><B><I>3)</I></B></TD><TD STYLE="text-align: justify"><B><I>The DeFi initiatives have been a massive distraction and utterly unsuccessful, as evidenced by:</I></B></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 21.25pt"><FONT STYLE="font-family: Wingdings">&#216;</FONT></TD><TD STYLE="text-align: justify">A huge event in crypto ETFs occurred in January 2024 when the SEC finally approved the launch of physical
Bitcoin ETFs. Despite the hype from WisdomTree about it being a significant player in crypto ETFs, it has managed to garner only 0.2%
in market share measured in AUM and is floundering in 8th place in issuer rankings;<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>7</SUP></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 21.25pt"><FONT STYLE="font-family: Wingdings">&#216;</FONT></TD><TD STYLE="text-align: justify">In Europe, where crypto ETFs have been listed for a number of years and WisdomTree was an early entrant,
the company is struggling in 4th place in issuer rankings.<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>8</SUP></FONT>
It has only garnered 6% in market share measured in AUM, but even worse, it only has 1% in market share of run-rate revenues;<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>9</SUP></FONT>
and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 21.25pt"><FONT STYLE="font-family: Wingdings">&#216;</FONT></TD><TD STYLE="text-align: justify"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">WT Prime has not been able to gain any traction, with run-rate revenues a mere $0.03 million per
annum.<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>10</SUP></FONT> The app is a poor offering compared to what firms
such as Schwab offer in our view and there is no logical reason for investors to sign up to it other than for those curious to see how
bad it is. Given the amount of time and money the Company has spent and wasted on this, the Board should expect it to be earning millions
in revenue by now &ndash; it is not. The Company has refused to provide information on WT Prime related revenue or KPIs that would allow
stockholders to properly evaluate its performance and hold the Board accountable.</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-right: 0; margin-left: 0">We believe
that, as a result of its misguided &lsquo;transformation&rsquo; strategy, WisdomTree has lost focus on the core ETF business, which despite
record AUM, suffers from poor profitability. Even though the ETF business model is highly scalable, management has yet to achieve the
requisite operating leverage that translates record growth in AUM and net inflows into comparable gains in earnings growth and profitability.&nbsp;</P>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<HR ALIGN="LEFT" SIZE="1" STYLE="width: 33%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>4</SUP></FONT>
As of end-March 2018 WisdomTree&rsquo;s AUM was $43 billion and the combined AUM of all four companies was $116 billion for the US businesses,
giving WisdomTree a market share of 37%. As of end-March 2024 WisdomTree&rsquo;s AUM was $78 billion and the combined AUM of all four
companies was $274 billion for the US businesses, giving WisdomTree a market share of 28%. Bloomberg.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>5</SUP></FONT>
Assuming 37% market share of combined AUM of $274 billion per note 4 above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>6</SUP></FONT>
Applying WisdomTree&rsquo;s current blended average fee rate of 36 bps pa to incremental AUM of $23 billion gives $83 million of additional
revenue. Assuming an incremental operating margin of 45% and a US tax rate of 21% gives $29 million of post-tax earnings, which at a PE
of 14x gives $412 million of value. Fee rate of 36 bps pa taken from WisdomTree Report of Monthly Metrics for March 2024. WisdomTree Q4
2023 Earnings Presentation states an incremental operating margin of over 50% but ETFS assumes only 45%. PE of 14x per note 3 above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>7</SUP></FONT>
These results are far worse if the legacy crypto ETF products of Grayscale and ProShares are included. Bloomberg.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>8</SUP></FONT>
Bloomberg.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>9</SUP></FONT>
Bloomberg.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>10
</SUP></FONT>Run rate revenues as of April 16, 2024 calculated using WisdomTree data on the Company&rsquo;s website.&nbsp;</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-left: 0"><B>The Board and Management Appear
Unwilling to Make Necessary Changes Unless Pushed by Stockholders. We Believe this &ldquo;VOTE AGAINST&rdquo; Campaign is the Only Way
of Getting the Board to Conduct an Independent Strategic Review to Unlock Value for all Stockholders</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-right: 0; margin-left: 0">Over the
past three years, we have attempted to address operational and governance failures through patient and direct engagement with the Board
and management of WisdomTree and by nominating individuals for election to the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-right: 0; margin-left: 0"><U>We believe
our prior proxy campaign and public engagement with the Company has highlighted important issues for stockholders including:</U></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">The value destruction suffered by stockholders, including ETFS, since we sold our market leading European
ETC business to WisdomTree in 2018.</TD></TR></TABLE>

<P STYLE="margin: 0 0 0 0.75in; font: 10pt Times New Roman, Times, Serif; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 5pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">ETFS&#8217; belief that the Board and management have been unable to articulate a credible strategy for
stockholder value creation &#8211; a situation that we believe persists today.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0.75in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">Our concerns about the Company&#8217;s WisdomTree Prime effort to diversify into DeFi as set forth above.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0.75in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">Poor corporate governance and flawed refreshment of the Board, including long-tenured directors and committee
chairs, a pay-for-performance disconnect, and the expansion of golden parachute change in control provisions that were triggered by a
loss of majority Board control by incumbents.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0.75in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">An urgent need for an infusion of skills, experience, expertise and fresh stockholder-focused perspective
on the Board.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0.75in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-right: 0; margin-left: 0">Unfortunately,
the resulting change to WisdomTree&rsquo;s Board, as a result of our engagement and the incremental Board change we were able to bring
about, has been insufficient to compel the Board to take the actions necessary to unlock value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-right: 0; margin-left: 0">We believe
the Company&rsquo;s significant undervaluation could be addressed by WisdomTree undertaking a strategic review to unlock the value of
its core ETF business. However, the Board&rsquo;s continued rejection of our good faith engagement on this issue led us to conclude that
the Board needed to hear from a plurality of the Company&rsquo;s stockholders before they will take action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-right: 0; margin-left: 0">As a referendum
on the Company&rsquo;s failed diversification strategy and the Board&rsquo;s refusal to unlock value through a strategic review process,
we believe voting <B>AGAINST</B> [__], [__] and [__] would send a strong message to the Board to undertake the much-needed strategic
review process to unlock the value inherent in WisdomTree&rsquo;s core ETF business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-right: 0; margin-left: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>PROPOSAL NO. 1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>ELECTION OF DIRECTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">As of the 2024 Annual Meeting,
the Company will have an annually elected Board composed of nine (9) directors. We believe that the terms of all nine (9) directors currently
serving on the Board expire at the 2024 Annual Meeting. For the reasons stated above, we are seeking your support at the 2024 Annual Meeting
to vote <B>AGAINST</B> the election of <B>[__]</B>, <B>[__]</B> and <B>[__]</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The Company has adopted
a majority vote standard for uncontested elections. Since we are not proposing an alternate slate of directors, the election is considered
to be uncontested despite our opposition to the election of certain of the Company Nominees. According to the Company&rsquo;s Bylaws (the
 &ldquo;Bylaws&rdquo;), a nominee for director shall be elected to the Board if the number of votes cast &ldquo;for&rdquo; such nominee&rsquo;s
election exceeds the number of votes cast &ldquo;against&rdquo; such nominee&rsquo;s election. The Bylaws also set forth a resignation
policy for uncontested elections, which provides that if an incumbent director is not re-elected, the director shall tender his or her
resignation to the Board. The Nominating and Governance Committee of the Board will make a recommendation to the Board on whether to accept
or reject the resignation, or whether other action should be taken. The Board will act on the recommendation of such committee and will
publicly disclose its decision within 90 days from the date of the certification of the election results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Accordingly, if we are
successful in soliciting your support to vote <B>AGAINST</B> the election of each of <B>[__], [__] and [__]</B> such that they receive
more votes &ldquo;against&rdquo; their election than votes &ldquo;for&rdquo; their election at the 2024 Annual Meeting, each of <B>[__],
[__] </B>and <B>[__] </B>must tender his or her resignation, effective immediately upon the failure to receive the required vote, and
the Board, upon the Nominating and Governance Committee&rsquo;s recommendation, must determine whether to accept the resignations tendered
by each of <B>[__], [__] </B>and <B>[__]</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Please note that the Company
Nominees are not the nominees of ETFS and are the nominees of the Company. Because the Company Nominees are not ETFS&rsquo; nominees,
they are not participants in this solicitation. We can provide no assurance that any of the Company Nominees will serve as directors if
elected. The names, backgrounds and qualifications of the Company Nominees, and other information about them, can be found in the Company&rsquo;s
proxy statement.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">WE STRONGLY URGE YOU TO VOTE &ldquo;AGAINST&rdquo;
THE ELECTION OF [__], [__] AND [__] ON THE ENCLOSED <U>GOLD</U> PROXY CARD</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><B>WE MAKE NO RECOMMENDATION
WITH RESPECT TO THE ELECTION OF THE OTHER COMPANY NOMINEES</B></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>PROPOSAL NO. 2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>RATIFICATION OF THE APPOINTMENT OF ERNST
 &amp; YOUNG LLP AS THE COMPANY&rsquo;S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">As discussed in further
detail in the Company&rsquo;s proxy statement, the Audit Committee of the Board has appointed Ernst &amp; Young LLP as the Company&rsquo;s
independent registered public accounting firm for the fiscal year ending December 31, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">As disclosed in the Company&rsquo;s
proxy statement, the Company&rsquo;s organizational documents do not require that the stockholders ratify the selection of Ernst &amp;
Young LLP as the Company&rsquo;s independent registered public accounting firm, but the Company is submitting the selection of Ernst &amp;
Young LLP for ratification by stockholders at the 2024 Annual Meeting. The Company has disclosed that if stockholders do not ratify the
selection, the Audit Committee will reconsider whether to retain Ernst &amp; Young LLP, but still may retain them. The Company has further
disclosed that, even if the selection is ratified, the Audit Committee, in its discretion, may change the appointment at any time during
the year if it determines that such a change would be in the best interests of the Company and its stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">According to the Company&rsquo;s
proxy statement, the affirmative vote of a majority of votes cast is necessary for the ratification of the appointment of Ernst &amp;
Young LLP as the Company&rsquo;s independent registered public accounting firm for the fiscal year ending December 31, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>WE MAKE NO RECOMMENDATION WITH RESPECT TO
THE RATIFICATION OF THE APPOINTMENT OF ERNST &amp; YOUNG LLP AS THE COMPANY&rsquo;S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR
THE FISCAL YEAR ENDING DECEMBER 31, 2024 AND INTEND TO VOTE OUR SHARES &ldquo;FOR&rdquo; THIS PROPOSAL</B></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>PROPOSAL NO. 3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0.5in"><B>VOTE ON AN ADVISORY RESOLUTION
TO APPROVE THE COMPENSATION OF THE COMPANY&rsquo;S NAMED EXECUTIVE OFFICERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">As discussed in further
detail in the Company&rsquo;s proxy statement, as required by Section 14A(a)(1) of the Securities Exchange Act of 1934 (the &ldquo;Exchange
Act&rdquo;), the Board is providing stockholders with an opportunity to vote on an advisory resolution to approve the compensation of
the Company&rsquo;s named executive officers, which is discussed in further detail in the section titled &ldquo;Executive Compensation
- Compensation Discussion and Analysis&rdquo; in the Company&rsquo;s proxy statement. Accordingly, the Board is asking stockholders to
approve the following resolution:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;RESOLVED, that the
Company&rsquo;s stockholders hereby approve, on an advisory basis, the compensation of the named executive officers, as disclosed in the
Company&rsquo;s proxy statement for the 2024 annual meeting of stockholders pursuant to the compensation disclosure rules of the Securities
and Exchange Commission, including the Compensation Discussion and Analysis, the Summary Compensation Table and the other compensation
related tables and disclosure.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">As disclosed in the Company&rsquo;s
proxy statement, as this vote is advisory, it will not be binding on the Board or the Compensation Committee of the Board and neither
the Board nor the Compensation Committee of the Board will be required to take any action as a result of the outcome of this vote. However,
the Board and the Compensation Committee of the Board will carefully consider the outcome of this vote when considering future executive
compensation policies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">According to the Company&rsquo;s
proxy statement, the affirmative vote of a majority of votes cast is necessary for the approval of the advisory resolution to approve
the compensation of the Company&rsquo;s named executive officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>WE MAKE NO RECOMMENDATION WITH RESPECT TO
THE ADVISORY VOTE ON EXECUTIVE COMPENSATION AND INTEND TO VOTE OUR SHARES &ldquo;AGAINST&rdquo; THIS PROPOSAL</B></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>PROPOSAL NO. 4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>NON-BINDING, ADVISORY VOTE ON THE FREQUENCY
OF FUTURE ADVISORY VOTES TO APPROVE THE COMPENSATION OF THE COMPANY&rsquo;S NAMED EXECUTIVE OFFICERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">As discussed in further
detail in the Company&rsquo;s proxy statement, as required by Section 14A(a)(2) of the Exchange Act, the Board is providing stockholders
with an opportunity to provide an advisory vote to recommend whether the vote on the advisory resolution on the compensation of the Company&rsquo;s
named executive officers should occur every one, two or three years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">As disclosed in the Company&rsquo;s
proxy statement, since this vote is advisory, the results will not be binding upon the Board and the Board may decide to hold an advisory
vote on executive compensation more or less frequently than the frequency receiving the most votes cast by stockholders. However, the
Board will carefully consider the outcome of this vote when considering the frequency of future advisory votes on executive compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">According to the Company&rsquo;s
proxy statement, the non-binding, advisory vote on the frequency of future advisory votes to approve the compensation of the Company&rsquo;s
named executive officers will be determined based on a plurality of the votes cast. This means that the option that receives the most
votes (every one year, every two years or every three years) will be approved on a non-binding, advisory basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>WE MAKE NO RECOMMENDATION WITH RESPECT TO
THIS PROPOSAL AND INTEND TO VOTE OUR SHARES &ldquo;ONE YEAR&rdquo;</B></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>PROPOSAL NO. 5</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>RATIFICATION OF THE APPROVAL BY THE BOARD
OF THE EXTENSION OF THE<BR>
STOCKHOLDER RIGHTS AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">As discussed in further
detail in the Company&rsquo;s proxy statement, on March 17, 2023, the Board adopted the Poison Pill, which has subsequently been amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">According to the Company&rsquo;s
proxy statement, stockholders are being asked to ratify the Board&rsquo;s approval of the extension of the Poison Pill to the close of
business on March 17, 2025. Stockholder ratification of the Board&rsquo;s approval of the extension of the Poison Pill is not required
by applicable law, or by the Company&rsquo;s Amended and Restated Certificate of Incorporation (as amended), Bylaws or other governing
documents. Nonetheless, according to the Company&rsquo;s proxy statement, the Board has determined to request stockholder ratification
of the Board&rsquo;s approval of the extension of the Poison Pill to determine the viewpoint of stockholders as to the advisability of
the Poison Pill. If stockholders do not ratify the Board&rsquo;s approval of the extension of the Poison Pill, it will expire automatically
at the close of business on the day after the 2024 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">According to the Company&rsquo;s
proxy statement, the affirmative vote of a majority of votes cast is necessary to ratify the Board&rsquo;s approval of the extension of
the Poison Pill.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>WE MAKE NO RECOMMENDATION WITH RESPECT TO
THE RATIFICATION OF THE BOARD&rsquo;S APPROVAL OF THE EXTENSION OF THE POISON PILL AND INTEND TO VOTE OUR SHARES &ldquo;AGAINST&rdquo;
THIS PROPOSAL</B></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>VOTING AND PROXY PROCEDURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Only stockholders of record
on the Record Date will be entitled to notice of and to vote at the 2024 Annual Meeting. Stockholders who sell their shares of Common
Stock before the Record Date (or acquire them without voting rights after the Record Date) may not vote such shares. Stockholders of record
on the Record Date will retain their voting rights in connection with the 2024 Annual Meeting even if they sell such shares after the
Record Date. Based on publicly available information, ETFS believes that the only outstanding class of securities of the Company entitled
to vote at the 2024 Annual Meeting is the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Shares of Common Stock
represented by properly executed <B>GOLD </B>proxy cards will be voted at the 2024 Annual Meeting as marked and, in the absence of specific
instructions, will be voted &ldquo;<B>AGAINST</B>&rdquo; the election of each of [__], [__] and [__] and <B>FOR </B>the election of the
remaining Company Nominees, <B>FOR</B> the ratification of the appointment of Ernst &amp; Young LLP as the Company&rsquo;s independent
registered public accounting firm for the fiscal year ending December 31, 2024, <B>AGAINST</B> the advisory resolution to approve the
compensation of the Company&rsquo;s named executive officers, <B>ONE YEAR</B> on the advisory vote on the frequency of future advisory
votes to approve the compensation of the Company&rsquo;s named executive officers, <B>AGAINST</B> the ratification of the Board&rsquo;s
approval of the extension of the Poison Pill and in the discretion of the persons named as proxies on all other matters as may properly
come before the 2024 Annual Meeting, as described herein.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The Company Nominees are
not the nominees of ETFS and are the nominees of the Company. The names, backgrounds and qualifications of the Company Nominees, and other
information about them, can be found in the Company&rsquo;s proxy statement. We can provide no assurance that any of the Company Nominees
will serve as directors if elected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>ATTENDING THE 2024 ANNUAL MEETING VIRTUALLY ON THE INTERNET</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company has disclosed that
the 2024 Annual Meeting will be conducted virtually over the Internet. Stockholders will not be able to attend the 2024 Annual Meeting
in person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">According to the Company&rsquo;s
proxy statement, stockholders of record can visit www.virtualshareholdermeeting.com/[&bull;] for instructions on how to attend, vote and
participate at the 2024 Annual Meeting. Any stockholder may attend and listen live to the webcast of the 2024 Annual Meeting over the
Internet at such site. Whether or not you expect to attend the 2024 Annual Meeting virtually, we respectfully urge you to vote over the
Internet, by telephone or by signing, dating and returning the enclosed <B>GOLD</B> proxy card as promptly as possible.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">According to the Company&rsquo;s
proxy statement, if you are a beneficial owner of shares (i.e., your shares are held in &ldquo;street name,&rdquo; meaning, in the name
of a brokerage firm, bank or a trustee) as of the Record Date, then you may ensure that your shares are represented and voted at the 2024
Annual Meeting by following the instructions provided in the voting instruction form or other materials provided to you by the brokerage
firm, bank, trustee or other nominee that holds your shares. If you do not provide voting instructions to your broker, then your shares
will not be voted as the 2024 Annual Meeting on any proposal with respect to which the broker does not have discretionary authority. &ldquo;Street
name&rdquo; stockholders who wish to vote their shares during the virtual 2024 Annual Meeting will need to obtain a legal proxy from the
bank, broker or other nominee in whose name their shares are registered. The instructions for voting over the telephone or the Internet
are provided on your proxy card.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The virtual 2024 Annual Meeting
will begin at [_] on [_], 2024. We encourage you to access the meeting site prior to the start time to allow ample time to log into the
meeting webcast and test your computer system. According to the Company&rsquo;s proxy statement, technicians will be available to assist
you with any technical difficulties you may have accessing the virtual website of the 2024 Annual Meeting or during the 2024 Annual Meeting.</P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Whether or not you plan to attend
the 2024 Annual Meeting, we urge you to sign, date and return the enclosed <B>GOLD</B> proxy card in the postage-paid envelope provided,
or vote via the Internet as instructed on the <B>GOLD</B> proxy card.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0"><B>QUORUM; BROKER NON-VOTES; DISCRETIONARY VOTING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">A quorum is the minimum
number of shares of Common Stock that must be represented at a duly called meeting in person or by proxy in order to legally conduct business
at the meeting. For the 2024 Annual Meeting, the presence, virtually or by proxy, of holders of at least a majority of the total number
of outstanding shares entitled to vote at the 2024 Annual Meeting is necessary to constitute a quorum for the transaction of business
at the 2024 Annual Meeting. Shares present virtually during the 2024 Annual Meeting will be considered shares of Common Stock represented
in person at the 2024 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Abstentions or withheld
votes are counted as present and entitled to vote for purposes of determining a quorum. Shares represented by &ldquo;broker non-votes&rdquo;
also are counted as present and entitled to vote for purposes of determining a quorum. However, if you hold your shares in street name
and do not provide voting instructions to your broker, your shares will not be voted on any proposal on which your broker does not have
discretionary authority to vote (a &ldquo;broker non-vote&rdquo;). Under applicable rules, your broker may have discretionary authority
to vote your shares at the 2024 Annual Meeting on the proposal to ratify the appointment of Ernst &amp; Young LLP as the independent registered
public accounting firm of the Company for the year ending December 31, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">If you are a stockholder
of record, you must deliver your vote by mail, attend the 2024 Annual Meeting virtually and vote, vote by Internet, or vote by telephone
in order to be counted in the determination of a quorum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>VOTES REQUIRED FOR APPROVAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><I>Election of Directors</I>
 &ndash; The Company has adopted a majority vote standard for uncontested director elections. This means that each nominee who receives
a number of votes cast &ldquo;for&rdquo; his or her election that exceeds the number of votes cast &ldquo;against&rdquo; his or her election
will be elected to the Board. According to the Company&rsquo;s proxy statement, abstentions and broker non-votes will have no effect on
the election of the directors. In a contested election, the required vote would be a plurality of votes cast.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The Bylaws set forth a
resignation policy for uncontested elections, pursuant to which any nominee who does not receive a majority of votes cast &ldquo;for&rdquo;
his or her election would be required to tender his or her resignation promptly following, and effective upon, the failure to receive
the required vote. The Nominating and Governance Committee of the Board will make a recommendation to the Board on whether to accept or
reject the resignation, or whether other action should be taken. The Board will act on the recommendation of such committee and will publicly
disclose its decision within 90 days from the date of the certification of the election results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><I>Ratification of the
Selection of Accounting Firm</I> &ndash; According to the Company&rsquo;s proxy statement, the affirmative vote of a majority of votes
cast is necessary for the ratification of the appointment of Ernst &amp; Young LLP as the Company&rsquo;s independent registered public
accounting firm for the fiscal year ending December 31, 2024. According to the Company&rsquo;s proxy statement, abstentions and broker
non-votes, if any, will have no effect on the proposal.</P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><I>Advisory Vote on Executive
Compensation</I> &ndash; According to the Company&rsquo;s proxy statement, the affirmative vote of a majority of votes cast is necessary
for the approval of the advisory resolution to approve the compensation of the Company&rsquo;s named executive officers. According to
the Company&rsquo;s proxy statement, abstentions and broker non-votes, if any, will have no effect on the proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><I>Advisory Vote on the
Frequency of Future Advisory Votes on Executive Compensation</I> &ndash; According to the Company&rsquo;s proxy statement, this proposal
will be determined based on a plurality of the votes cast. This means that the option that receives the most votes (every one year, every
two years or every three years) will be approved on a non-binding, advisory basis. According to the Company&rsquo;s proxy statement, abstentions
and broker non-votes, if any, will have no effect on the proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><I>Ratification of the
Board&rsquo;s Approval of the Extension of the Stockholder Rights Agreement </I>&ndash; According to the Company&rsquo;s proxy statement,
the affirmative vote of a majority of votes cast is necessary for the ratification of the Board&rsquo;s approval of the extension of the
Poison Pill. According to the Company&rsquo;s proxy statement, abstentions and broker non-votes, if any, will have no effect on the proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Under applicable Delaware
law, none of the holders of Common Stock are entitled to appraisal rights in connection with any matter to be acted on at the 2024 Annual
Meeting. If you sign and submit your <B>GOLD </B>proxy card without specifying how you would like your shares voted, your shares will
be voted in accordance with ETFS&rsquo; recommendations specified herein and in accordance with the discretion of the persons named on
the <B>GOLD </B>proxy card with respect to any other matters that may be voted upon at the 2024 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>REVOCATION OF PROXIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Stockholders of the Company
may revoke their proxies at any time prior to exercise by attending the 2024 Annual Meeting and voting virtually (although, attendance
at the 2024 Annual Meeting will not in and of itself constitute revocation of a proxy) or by delivering a written notice of revocation.
The delivery of a written revocation or a subsequently dated proxy which is properly completed will constitute a revocation of any earlier
proxy. The revocation may be delivered either to ETFS in care of Saratoga at the address set forth on the back cover of this Proxy Statement
or to the Secretary of the Company at the Company&rsquo;s principal executive offices located at 250 West 24<SUP>th</SUP> Street, 3<SUP>rd</SUP>
Floor West, New York, NY 10119 or any other address provided by the Company. Although a revocation is effective if delivered to the Company,
we request that either the original or photostatic copies of all revocations be mailed to ETFS in care of Saratoga at the address set
forth on the back cover of this Proxy Statement so that we will be aware of all revocations and can more accurately determine if and when
proxies have been received from the holders of record on the Record Date of a majority of the outstanding shares entitled to be voted
at the 2024 Annual Meeting. Additionally, Saratoga may use this information to contact stockholders who have revoked their proxies in
order to solicit later dated proxies to vote &ldquo;<B>AGAINST</B>&rdquo; the election of each of [__], [__] and [__].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>IF YOU WISH TO VOTE &quot;AGAINST&rdquo;
THE ELECTION OF [__], [__] AND [__] TO THE BOARD, PLEASE SIGN, DATE AND RETURN PROMPTLY THE ENCLOSED <U>GOLD</U> PROXY CARD IN THE POSTAGE-PAID
ENVELOPE PROVIDED.</B></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B><BR STYLE="clear: both">
SOLICITATION OF PROXIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The solicitation of proxies
pursuant to this Proxy Statement is being made by ETFS. Proxies may be solicited by mail, facsimile, telephone, telegraph, Internet, in
person and by advertisements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">ETFS has entered into an
agreement with Saratoga for solicitation and advisory services in connection with this solicitation, for which Saratoga will receive a
fee not to exceed $[_____], together with reimbursement for its reasonable out-of-pocket expenses, and will be indemnified against certain
liabilities and expenses, including certain liabilities under the federal securities laws. Saratoga will solicit proxies from individuals,
brokers, banks, bank nominees and other institutional holders. We have requested banks, brokerage houses and other custodians, nominees
and fiduciaries to forward all solicitation materials to the beneficial owners of the shares of Common Stock they hold of record. ETFS
will reimburse these record holders for their reasonable out-of-pocket expenses in so doing. In addition, directors, officers, members
and certain other employees of ETFS may solicit proxies as part of their duties in the normal course of their employment without any additional
compensation. It is anticipated that Saratoga will employ approximately [____] persons to solicit stockholders for the 2024 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The entire expense of soliciting
proxies is being borne by ETFS Capital. Costs of this solicitation of proxies are currently estimated to be approximately $[___________]
(including, but not limited to, fees for attorneys, solicitors and other advisors, and other costs incidental to the solicitation). ETFS
Capital estimates that through the date hereof its expenses in connection with this solicitation are approximately $[___________]. To
the extent legally permissible, if ETFS Capital is successful in its proxy solicitation, ETFS Capital intends to seek reimbursement from
the Company for the expenses it incurs in connection with this solicitation. ETFS Capital does not intend to submit the question of such
reimbursement to a vote of security holders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>ADDITIONAL PARTICIPANT INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The Participants in this
proxy solicitation are ETFS Capital and Graham Tuckwell. ETFS Capital is a private company incorporated in the Bailiwick of Jersey, Channel
Islands, and Graham Tuckwell is a citizen of Australia. The principal business of ETFS Capital is serving as an investment company. The
principal occupation of Mr. Tuckwell is serving as the Founder and Executive Chairman of ETFS Capital. The principal business address
of ETFS Capital is Ordnance House, 31 Pier Road, St. Helier, Jersey JE2 4XW. The principal business address of Mr. Tuckwell is 15 Rathbone
Place, London W1T 1HU, United Kingdom.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">As of the date hereof,
ETFS Capital directly beneficially owns 15,250,000 shares of Common Stock as well as 14,750 shares of Series A Preferred Stock. Pursuant
to the Series A Certificate of Designation, no Holder shall have the right to convert any shares of Series A Preferred Stock into shares
of Common Stock if, after such conversion, such Holder and certain of its affiliates would be deemed to beneficially own, as determined
in accordance with Section 13(d) of the Exchange Act, more than 9.99% of the Company&rsquo;s then outstanding shares of Common Stock (the
 &ldquo;Beneficial Ownership Limitation&rdquo;). As of the date hereof, none of the 14,750 shares of Series A Preferred Stock is currently,
and is not expected within 60 days to be, convertible into any shares of Common Stock due to the Beneficial Ownership Limitation. Neither
ETFS Capital nor Mr. Tuckwell has entered into any transactions in the securities of the Company during the past two years. As the Executive
Chairman and controlling shareholder of ETFS Capital, Mr. Tuckwell may be deemed to be an indirect beneficial owner of the 15,250,000
shares of Common Stock directly owned by ETFS Capital and the 14,750 shares of Series A Preferred Stock directly owned by ETFS Capital.</P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Each Participant may be
deemed to be a member of a &ldquo;group&rdquo; with the other Participants for the purposes of Section 13(d)(3) of the Exchange Act, and
such group may be deemed to beneficially own the 15,250,000 shares of Common Stock owned in the aggregate by all of the Participants,
as well as the 14,750 shares of the Series A Preferred Stock. Each of the Participants disclaims beneficial ownership of the shares of
Common Stock that he or it does not directly own.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The shares of Common Stock
and Series A Preferred Stock beneficially owned by ETFS Capital and Mr. Tuckwell were acquired on April 11, 2018 pursuant to the Share
Sale Agreement, dated as of November 13, 2017 (the &ldquo;Share Sale Agreement&rdquo;), by and among the Company, WisdomTree International
Holdings Ltd, a wholly-owned subsidiary of the Company, and ETFS Capital. In connection with the Share Sale Agreement, in April 2018 the
Company assumed a deferred consideration obligation to ETFS Capital. The obligation consisted of fixed payments to ETFS Capital of physical
gold bullion equating to 9,500 ounces of gold per year through March 31, 2058 and thereafter 6,333 ounces of gold continuing into perpetuity
(&ldquo;Contractual Gold Payments&rdquo;). The Contractual Gold Payments were paid from management fee income generated by any of the
Company&rsquo;s sponsored financial products backed by physical gold. Pursuant to internal arrangements with ETFS Capital, Mr. Tuckwell
had an indirect interest in the Contractual Gold Payments made by the Company to ETFS Capital. On May 10, 2023, the Company entered into
and closed on a Sale, Purchase and Assignment Deed (the &ldquo;SPA Agreement&rdquo;) relating to the Contractual Gold Payments with WisdomTree
International Holdings Ltd, Electra Target HoldCo Limited, ETFS Capital, the World Gold Council, Gold Bullion Holdings (Jersey) Limited
(&ldquo;GBH&rdquo;), a subsidiary of WGC, Mr. Tuckwell and Rodber Investments Limited (&ldquo;RIL&rdquo;), an entity controlled by Mr.
Tuckwell, to extinguish the Company&rsquo;s obligations relating to the Contractual Gold Payments. Pursuant to the SPA Agreement, the
Company issued 13,087 shares of Series C Non-Voting Convertible Preferred Stock, $0.01 par value per share (the &ldquo;Series C Preferred
Shares&rdquo;), which were convertible into 13,087,000 Shares to GBH (but were subsequently repurchased by the Company) and paid an aggregate
of approximately $50 million. The consideration paid pursuant to the SPA Agreement resulted in GBH receiving approximately $4.4 million
in cash and the Series C Preferred Shares, and RIL receiving approximately $45.6 million in cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Except as set forth in
this Proxy Statement (including the Schedules hereto), (i) during the past 10 years, no Participant has been convicted in a criminal proceeding
(excluding traffic violations or similar misdemeanors); (ii) no Participant directly or indirectly beneficially owns any securities of
the Company; (iii) no Participant owns any securities of the Company which are owned of record but not beneficially; (iv) no Participant
has purchased or sold any securities of the Company during the past two years; (v) no part of the purchase price or market value of the
securities of the Company owned by any Participant is represented by funds borrowed or otherwise obtained for the purpose of acquiring
or holding such securities; (vi) no Participant is, or within the past year was, a party to any contract, arrangements or understandings
with any person with respect to any securities of the Company, including, but not limited to, joint ventures, loan or option arrangements,
puts or calls, guarantees against loss or guarantees of profit, division of losses or profits, or the giving or withholding of proxies;
(vii) no associate of any Participant owns beneficially, directly or indirectly, any securities of the Company; (viii) no Participant
owns beneficially, directly or indirectly, any securities of any parent or subsidiary of the Company; (ix) no Participant or any of his
or its associates or immediate family members was a party to any transaction, or series of similar transactions, since the beginning of
the Company&rsquo;s last fiscal year, or is a party to any currently proposed transaction, or series of similar transactions, to which
the Company or any of its subsidiaries was or is to be a party, in which the amount involved exceeds $120,000; (x) no Participant or any
of his or its associates has any arrangement or understanding with any person with respect to any future employment by the Company or
its affiliates, or with respect to any future transactions to which the Company or any of its affiliates will or may be a party; (xi)
no Participant has a substantial interest, direct or indirect, by securities holdings or otherwise in any matter to be acted on at the
2024 Annual Meeting; (xii) no Participant holds any positions or offices with the Company; (xiii) no Participant has a family relationship
with any director, executive officer, or person nominated or chosen by the Company to become a director or executive officer and (xiv)
no companies or organizations, with which any of the Participants has been employed in the past five years, is a parent, subsidiary or
other affiliate of the Company.</P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">There are no material proceedings
to which any Participant or any of his or its associates is a party adverse to the Company or any of its subsidiaries or has a material
interest adverse to the Company or any of its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>OTHER MATTERS AND ADDITIONAL INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">ETFS is unaware of any
other matters to be considered at the 2024 Annual Meeting. However, should other matters, which ETFS is not aware of at a reasonable time
before this solicitation, be brought before the 2024 Annual Meeting, the persons named as proxies on the enclosed <B>GOLD </B>proxy card
will vote on such matters in their discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Some banks, brokers and
other nominee record holders may be participating in the practice of &ldquo;householding&rdquo; proxy statements and annual reports. This
means that only one copy of this Proxy Statement may have been sent to multiple stockholders in your household. We will promptly deliver
a separate copy of the document to you if you write to our proxy solicitor, Saratoga, at the address set forth on the back cover of this
Proxy Statement, or call toll free at (888) 368-0379. If you want to receive separate copies of our proxy materials in the future, or
if you are receiving multiple copies and would like to receive only one copy for your household, you should contact your bank, broker
or other nominee record holder, or you may contact our proxy solicitor at the above address and phone number.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The information concerning
the Company and the proposals in the Company&rsquo;s proxy statement contained in this Proxy Statement has been taken from, or is based
upon, publicly available documents on file with the SEC and other publicly available information. Although we have no knowledge that would
indicate that statements relating to the Company contained in this Proxy Statement, in reliance upon publicly available information, are
inaccurate or incomplete, to date we have not had access to the books and records of the Company, were not involved in the preparation
of such information and statements and are not in a position to verify such information and statements. All information relating to any
person other than the Participants is given only to our knowledge.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">This Proxy Statement is
dated [________], 2024. You should not assume that the information contained in this Proxy Statement is accurate as of any date other
than such date, and the mailing of this Proxy Statement to stockholders shall not create any implication to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>STOCKHOLDER PROPOSALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">According to the Company&rsquo;s
proxy statement, stockholders who wish to present proposals for inclusion in the Company&rsquo;s proxy materials for the 2025 Annual Meeting
of Stockholders (the &ldquo;2025 Annual Meeting&rdquo;) may do so by following the procedures prescribed in Rule 14a-8 under the Exchange
Act. The Company&rsquo;s Secretary must receive stockholder proposals intended to be included in the Company&rsquo;s proxy statement and
form of proxy relating to the 2025 Annual Meeting made under Rule 14a-8 by [_________], 2025. Any proposal of business must be mailed
to Marci Frankenthaler, Secretary, WisdomTree, Inc., 250 West 34<SUP>th</SUP> Street, 3<SUP>rd</SUP> Floor, New York, NY 10119. The Company
also encourages stockholders to submit any such proposals by email to mfrankenthaler@wisdomtree.com.</P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">According to the Company&rsquo;s
proxy statement, the Bylaws permit a stockholder or group of up to 20 stockholders, who meet the eligibility requirements of the Bylaws,
to utilize the &ldquo;proxy access&rdquo; Bylaw provision. &ldquo;Proxy access&rdquo; can be used to nominate up to the greater of two
nominees or 25% of the total number of directors who are members of the Board as of the date that the stockholder(s) notifies the Company
of the intent to utilize proxy access (the &ldquo;proxy access notice&rdquo;). Director nominations submitted under this Bylaw provision
must be delivered to the Company no earlier than [______], 2025, and no later than [______], 2025. The proxy access notice must comply
with the requirements in the Bylaws. To be eligible to utilize the proxy access Bylaw provision, the stockholder(s) must have continuously
owned at least 3% of the outstanding Common Stock for at least three years as of the date of the proxy access notice. Consistent with
standard market practice, proxy access is only available to eligible stockholders who acquired the Common Stock in the ordinary course
of business and not with the intent to change or influence control at the Company and who do not presently have such intent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">According to the Company&rsquo;s
proxy statement, under the current Bylaws, proposals of business other than those to be included in the Company&rsquo;s proxy materials
following the procedures described in Rule 14a-8 and nominations for directors may be made by any stockholder who was a stockholder of
record at the time of the giving of notice provided for in the Bylaws, who is entitled to vote at the meeting, who is present in person
or by proxy at the meeting and who complies with the notice procedures set forth in the Bylaws (i.e., notice must be timely given and
contain the information required by the Bylaws). To be timely, a notice with respect to the 2025 Annual Meeting must be delivered to the
Company&rsquo;s Secretary no earlier than [_______], 2025 and no later than [______], 2025, unless the date of the 2025 Annual Meeting
is advanced by more than 30 days or delayed by more than 60 days from the anniversary date of the 2024 Annual Meeting, in which event
the Bylaws provide different notice requirements. Any proposal of business or nomination must be mailed to Marci Frankenthaler, Secretary,
WisdomTree, Inc., 250 West 34th Street, 3<SUP>rd</SUP> Floor, New York, NY 10119. The Company also encourages stockholders to submit any
such proposal of business or nomination by email to mfrankenthaler@wisdomtree.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">In addition to the requirements
set forth above, to comply with the universal proxy rules, stockholders who intend to solicit proxies in support of director nominees
other than the Company&rsquo;s nominees must provide notice by the same deadline noted above to submit a notice of nomination at an annual
meeting of stockholders. Such notice must comply with the additional requirements of Rule 14a-19(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The information set forth
above regarding the procedures for submitting stockholder proposals for consideration at the 2025 Annual Meeting is based on information
contained in the Company&rsquo;s proxy statement and the Bylaws. The incorporation of this information in this Proxy Statement should
not be construed as an admission by ETFS that such procedures are legal, valid or binding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>CERTAIN ADDITIONAL INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">WE HAVE OMITTED FROM THIS
PROXY STATEMENT CERTAIN DISCLOSURE REQUIRED BY APPLICABLE LAW THAT IS EXPECTED TO BE INCLUDED IN THE COMPANY&rsquo;S PROXY STATEMENT RELATING
TO THE 2024 ANNUAL MEETING BASED ON OUR RELIANCE ON RULE 14A-5(C) UNDER THE EXCHANGE ACT. THIS DISCLOSURE IS EXPECTED TO INCLUDE, AMONG
OTHER THINGS, CURRENT BIOGRAPHICAL INFORMATION ON THE COMPANY&rsquo;S DIRECTORS AND EXECUTIVE OFFICERS, INFORMATION CONCERNING EXECUTIVE
COMPENSATION AND DIRECTOR COMPENSATION, INFORMATION CONCERNING THE COMMITTEES OF THE BOARD AND OTHER INFORMATION CONCERNING THE BOARD,
INFORMATION CONCERNING CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS, INFORMATION ABOUT THE COMPANY&rsquo;S INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM AND OTHER IMPORTANT INFORMATION. <B>STOCKHOLDERS ARE DIRECTED TO REFER TO THE COMPANY&rsquo;S PROXY STATEMENT FOR
THE FOREGOING INFORMATION, INCLUDING INFORMATION REQUIRED BY ITEM 7 OF SCHEDULE 14A WITH REGARD TO THE COMPANY&rsquo;S NOMINEES. STOCKHOLDERS
CAN ACCESS THE COMPANY&rsquo;S PROXY STATEMENT AND OTHER RELEVANT DOCUMENTS DISCLOSING THIS INFORMATION, WITHOUT COST, ON THE SEC&rsquo;S
WEBSITE AT WWW.SEC.GOV</B>.</P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">SEE SCHEDULE I FOR INFORMATION
REGARDING PERSONS WHO BENEFICIALLY OWN MORE THAN 5% OF THE SHARES AND THE OWNERSHIP OF THE SHARES BY THE DIRECTORS AND MANAGEMENT OF THE
COMPANY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The information concerning
the Company contained in this Proxy Statement and the Schedule attached hereto has been taken from, or is based upon, publicly available
documents on file with the SEC and other publicly available information. Although we have no knowledge that would indicate that statements
relating to the Company contained in this Proxy Statement, in reliance upon publicly available information, are inaccurate or incomplete,
to date we have not had access to the books and records of the Company, were not involved in the preparation of such information and statements
and are not in a position to verify such information and statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>Your vote is important. No matter how many
or how few shares of Common Stock you own, please vote AGAINST the election of each of [__], [__] and [__] by marking, signing, dating
and mailing the enclosed <U>GOLD</U> proxy card promptly.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 3.5in"><B>ETFS Capital Limited<BR>
<BR>
_________________, 2024 </B></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 3.5in"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B><U>SCHEDULE I</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITY OWNERSHIP OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B><I>The following table
is reprinted from the Company&rsquo;s preliminary proxy statement filed with the SEC on April 12, 2024.</I></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; border-top: Black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 8pt; padding-bottom: 8pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt; color: #0047BA"><B>Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Source Sans Pro,sans-serif; margin: 8pt 0 0">In computing the number of shares beneficially owned by a person and
the percentage ownership of that person, we have included the shares the person has the right to acquire within 60 days of March 31,
2024 upon the exercise of any option, warrant or other right or conversion of any security. The shares that a stockholder has the right
to acquire within 60 days, however, are not included in the computation of the percentage ownership of any other stockholder.<BR>
 &nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="background-color: #0047BA">
    <TD STYLE="width: 75%; border-top: Black 1pt solid; border-bottom: #0047BA 1pt solid; padding-top: 3pt; padding-right: 3pt; padding-left: 3pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt; color: white"><B>Beneficial Holder</B></FONT></TD>
    <TD STYLE="width: 14%; border-top: Black 1pt solid; border-bottom: #0047BA 1pt solid; padding-top: 3pt; padding-right: 3pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt; color: white"><B>Number</B></FONT></TD>
    <TD STYLE="width: 11%; border-top: Black 1pt solid; border-bottom: #0047BA 1pt solid; padding-top: 3pt; padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt; color: white"><B>Percentage</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #EDEDEE">
    <TD STYLE="padding-top: 4pt; padding-left: 13pt; text-indent: -10pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt"><B><I>Executive Officers</I></B></FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 4pt; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">Bryan Edmiston<SUP>(1)</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 14pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">195,688</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 5pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">0.1</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #EDEDEE">
    <TD STYLE="padding-top: 4pt; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">Marci Frankenthaler<SUP>(2)</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 14pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">242,634</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 5pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">0.2</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 4pt; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">R. Jarrett Lilien<SUP>(3)</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 14pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">951,728</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 5pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">0.6</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #EDEDEE">
    <TD STYLE="padding-top: 4pt; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">Alexis Marinof<SUP>(4)</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 14pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">272,925</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 5pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">0.2</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 4pt; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">William Peck<SUP>(5)</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 14pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">196,681</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 5pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">0.1</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #EDEDEE">
    <TD STYLE="padding-top: 4pt; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">Jonathan Steinberg<SUP>(6)</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 7pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">9,173,636</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 5pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">6.0</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 4pt; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">David Yates<SUP>(7)</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 14pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">154,433</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 5pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">0.1</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #EDEDEE">
    <TD STYLE="padding-top: 4pt; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">Peter M. Ziemba<SUP>(8)</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 7pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">1,048,386</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 5pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">0.7</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 4pt; padding-left: 13pt; text-indent: -10pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt"><B><I>Directors and Nominees</I></B></FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #EDEDEE">
    <TD STYLE="padding-top: 4pt; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">Lynn S. Blake<SUP>(9)</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 19pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">20,835</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 13pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">*</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 4pt; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">Anthony Bossone<SUP>(10)</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 14pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">610,704</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 5pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">0.4</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #EDEDEE">
    <TD STYLE="padding-top: 4pt; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">Smita Conjeevaram<SUP>(11)</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 19pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">57,345</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 13pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">*</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 4pt; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">Rilla Delorier<SUP>(12)</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 19pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">11,828</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 13pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">*</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #EDEDEE">
    <TD STYLE="padding-top: 4pt; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">Daniela Mielke<SUP>(13)</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 19pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">16,639</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 13pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">*</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 4pt; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">Shamla Naidoo<SUP>(14)</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 19pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">14,662</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 13pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">*</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #EDEDEE">
    <TD STYLE="padding-top: 4pt; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">Win Neuger<SUP>(15)</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 14pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">138,182</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 5pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">0.1</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 4pt; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">Tonia Pankopf<SUP>(16)</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 19pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">14,662</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 13pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">*</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #EDEDEE">
    <TD STYLE="padding-top: 4pt; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">All directors and executive officers as a group (16 persons)</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">13,120,968</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 5pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">8.6</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 4pt; padding-left: 13pt; text-indent: -10pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt"><B><I>Other 5% or Greater Stockholders</I></B></FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #EDEDEE">
    <TD STYLE="padding-top: 4pt; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">BlackRock, Inc.<SUP>(17)</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">18,335,140</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">12.1</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 4pt; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">ETFS Capital Limited<SUP>(18)</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">15,250,000</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">10.0</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #EDEDEE">
    <TD STYLE="padding-top: 4pt; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">The Vanguard Group, Inc.<SUP>(19)</SUP></FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">14,603,944</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 5pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">9.6</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 4pt; padding-left: 30pt; text-indent: -10pt"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">ArrowMark Colorado Holdings LLC<SUP>(20)</SUP></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">13,495,079</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 2.25pt; padding-left: 5pt; text-align: center"><FONT STYLE="font-family: Source Sans Pro,sans-serif; font-size: 10pt">8.9</FONT></TD></TR>
  </TABLE>
<P STYLE="margin: 0; font: 10pt Source Sans Pro,sans-serif"></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 28; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%">I-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Source Sans Pro,sans-serif; margin-top: 10pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">*</TD><TD>Less than 0.1%.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Source Sans Pro,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>Includes 130,631 shares of restricted stock that do not vest within 60 days of March 31, 2024 and are not transferable by Mr. Edmiston
until they vest, but over which he exercises voting power.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Source Sans Pro,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>Includes 134,028 shares of restricted stock that do not vest within 60 days of March 31, 2024 and are not transferable by Ms. Frankenthaler
until they vest, but over which she exercises voting power.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Source Sans Pro,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(3)</TD><TD>Includes 324,382 shares of restricted stock that do not vest within 60 days of March 31, 2024 and are not transferable by Mr. Lilien
until they vest, but over which he exercises voting power.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Source Sans Pro,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(4)</TD><TD>Includes 147,651 shares of restricted stock that do not vest within 60 days of March 31, 2024 and are not transferable by Mr. Marinof
until they vest, but over which he exercises voting power.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Source Sans Pro,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(5)</TD><TD>Includes 114,266 shares of restricted stock that do not vest within 60 days of March 31, 2024 and are not transferable by Mr. Peck
until they vest, but over which he exercises voting power.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Source Sans Pro,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(6)</TD><TD>Includes (i) 798 shares of common stock owned by Mr. Steinberg&rsquo;s spouse with whom he may be deemed to share voting power; (ii)
16,889 shares of common stock held in a joint account with Mr. Steinberg&rsquo;s spouse with whom he shares voting power; and (iii) 555,409
shares of restricted stock that do not vest within 60 days of March 31, 2024 and are not transferable by Mr. Steinberg until they vest,
but over which he exercises voting power.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Source Sans Pro,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(7)</TD><TD>Includes 104,854 shares of restricted stock that do not vest within 60 days of March 31, 2024 and are not transferable by Mr. Yates
until they vest, but over which he exercises voting power.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Source Sans Pro,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(8)</TD><TD>Includes 153,588 shares of restricted stock that do not vest within 60 days of March 31, 2024 and are not transferable by Mr. Ziemba
until they vest, but over which he exercises voting power.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Source Sans Pro,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(9)</TD><TD>Excludes 14,662 deferred restricted stock units that do not vest within 60 days of March 31, 2024.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Source Sans Pro,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(10)</TD><TD>Excludes 14,662 deferred restricted stock units that do not vest within 60 days of March 31, 2024.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Source Sans Pro,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(11)</TD><TD>Includes 14,662 shares of restricted stock that do not vest within 60 days of March 31, 2024 and are not transferable by Ms. Conjeevaram
until they vest, but over which she exercises voting power.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Source Sans Pro,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(12)</TD><TD>Includes 11,828 shares of restricted stock that do not vest within 60 days of March 31, 2024 and are not transferable by Ms. Delorier
until they vest, but over which she exercises voting power.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Source Sans Pro,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(13)</TD><TD>Excludes 14,662 deferred restricted stock units that do not vest within 60 days of March 31, 2024.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Source Sans Pro,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(14)</TD><TD>Includes 14,662 shares of restricted stock that do not vest within 60 days of March 31, 2024 and are not transferable by Ms. Naidoo
until they vest, but over which she exercises voting power.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Source Sans Pro,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(15)</TD><TD>Includes 14,662 shares of restricted stock that do not vest within 60 days of March 31, 2024 and are not transferable by Mr. Neuger
until they vest, but over which he exercises voting power.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Source Sans Pro,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(16)</TD><TD>Includes 14,662 shares of restricted stock that do not vest within 60 days of March 31, 2024 and are not transferable by Ms. Pankopf
until they vest, but over which she exercises voting power.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Source Sans Pro,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(17)</TD><TD>Information reported pursuant to a Schedule 13G/A filed with the SEC on January 23, 2024. Blackrock, Inc. has filed as a parent holding
company or control person on behalf of certain subsidiaries, none of which (except for BlackRock Fund Advisors) individually own 5% or
more of our outstanding common stock. The business address of Blackrock is 50 Hudson Yards, New York, NY 10001.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Source Sans Pro,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(18)</TD><TD>Information reported pursuant to a Schedule 13D/A filed with the SEC on March 25, 2024. The shares indicated in the table are directly
owned by ETFS Capital. Graham Tuckwell, who is the controlling shareholder of ETFS Capital, may be deemed an indirect beneficial owner
of the shares of common stock directly owned by ETFS Capital and shares voting and dispositive power over such shares. In addition to
the shares indicated in the table, ETFS Capital directly owns, and Mr. Tuckwell indirectly beneficially owns, 14,750 shares of our Series
A Non-Voting Convertible Preferred Stock, which are convertible into 14,750,000 shares of common stock at the holder&rsquo;s option. The
Certificate of Designations for the Series A Non-Voting Convertible Preferred Stock restricts ETFS Capital from converting such stock
into common stock if the conversion would result in ETFS Capital owning more than 9.99% of our outstanding common stock. Each of ETFS
Capital and Graham Tuckwell disclaims beneficial ownership in all such shares of common stock, except to the extent of its respective
pecuniary interest therein. The address of the principal office of ETFS Capital is Ordnance House, 31 Pier Road, St. Helier, Jersey JE2
4XW. The address of the principal office of Mr. Tuckwell is 43 Mary St., Hawthorn VIC 3122, Australia.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Source Sans Pro,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(19)</TD><TD>Information reported pursuant to a Schedule 13G/A filed with the SEC on February 13, 2024. The shares indicated in the table are beneficially
owned by The Vanguard Group, Inc. in its capacity as investment adviser and are owned of record by its clients. Vanguard reports that
it has no sole voting power and shares voting power with respect to 246,658 shares, and that it has sole dispositive power with respect
to 14,227,184 shares and shares dispositive power with respect to 376,760 shares. The business address of Vanguard is 100 Vanguard Blvd.,
Malvern, PA 19355.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Source Sans Pro,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(20)</TD><TD>Information reported pursuant to a Schedule 13G/A filed with the SEC on February 14, 2024. The business address of ArrowMark Colorado
Holdings LLC is 100 Fillmore Street, Suite 325, Denver, CO 80206.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%">I-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>IMPORTANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Tell the Board what you
think! Your vote is important. No matter how many shares of Common Stock you own, please give ETFS your proxy to vote <B>AGAINST </B>the
election of each of [__], [__] and [__] and in accordance with ETFS&rsquo; recommendations on the other proposals on the agenda for the
2024 Annual Meeting by:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">SIGNING, DATING and MAILING the enclosed <B>GOLD </B>proxy card TODAY in the envelope provided (no postage
is required if mailed in the United States).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">VOTING BY INTERNET using the unique &#8220;control number&#8221; and following the instructions that appear
on your <B>GOLD</B> proxy card.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">You may vote your shares
virtually at the 2024 Annual Meeting; however, even if you plan to attend the 2024 Annual Meeting virtually, we recommend that you submit
your <B>GOLD</B> proxy card by mail by the applicable deadline so that your vote will still be counted if you later decide not to attend
the 2024 Annual Meeting. <B>If any of your shares of Common Stock are held in the name of a brokerage firm, bank, bank nominee or other
institution, only it can vote such shares of Common Stock and only upon receipt of your specific instructions.</B> Depending upon your
broker or custodian, you may be able to vote either by toll-free telephone or by the Internet. Please refer to the enclosed voting form
for instructions on how to vote electronically. You may also vote by signing, dating and returning the enclosed <B>GOLD</B> voting form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">If you have any questions
or require any additional information concerning this Proxy Statement, please contact Saratoga at the address set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; border: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>If you have any questions, require assistance in
    voting your <B>GOLD</B> proxy card,</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>or need additional copies of ETFS&rsquo; proxy materials,</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>please contact Saratoga at the phone numbers listed
    below.</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="image_003.jpg" ALT="Saratoga Proxy Consulting LLC" STYLE="height: 83px; width: 317px"></P>
    <P STYLE="font: 10pt Franklin Gothic Book,sans-serif; margin: 0; text-align: center"><B>520 8<SUP>th</SUP> Avenue, 14<SUP>th</SUP> Floor</B></P>
    <P STYLE="font: 10pt Franklin Gothic Book,sans-serif; margin: 0; text-align: center"><B>New York, NY 10018</B></P>
    <P STYLE="font: 10pt Franklin Gothic Book,sans-serif; margin: 0; text-align: center"><B>(212) 257-1311</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 1.25in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><I>Stockholders call toll free at (888) 368-0379<BR>
    Email: <FONT STYLE="color: #0563C1">info@saratogaproxy.com</FONT></I></B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify"></P>

<!-- Field: Page; Sequence: 30; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="color: red"><B>PRELIMINARY COPY
SUBJECT TO COMPLETION<BR>
DATED APRIL 17, 2024 </B></FONT><B><BR>
<BR>
WISDOMTREE, INC.<BR>
<BR>
2024 ANNUAL MEETING OF STOCKHOLDERS<BR>
<BR>
THIS PROXY IS SOLICITED ON BEHALF OF ETFS CAPITAL LIMITED AND THE OTHER PARTICIPANTS IN ITS PROXY SOLICITATION<BR>
<BR>
THE BOARD OF DIRECTORS OF WISDOMTREE, INC.<BR>
IS NOT SOLICITING THIS PROXY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>P&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;R&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;O&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;X&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Y</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The undersigned appoints
Graham Tuckwell, Andrew Freedman and John Ferguson, and each of them, attorneys and agents with full power of substitution to vote all
shares of common stock of WisdomTree, Inc. (the &ldquo;Company&rdquo;) which the undersigned would be entitled to vote if personally present
at the 2024 annual meeting of stockholders of the Company scheduled to be held virtually at www.virtualshareholdermeeting.com/[&bull;]
on [_______] at [_:__] (including any adjournments or postponements thereof and any meeting called in lieu thereof, the &ldquo;2024 Annual
Meeting&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The undersigned hereby
revokes any other proxy or proxies heretofore given to vote or act with respect to the shares of common stock of the Company held by the
undersigned, and hereby ratifies and confirms all action the herein named attorneys and proxies, their substitutes, or any of them may
lawfully take by virtue hereof. If properly executed, this Proxy will be voted as directed on the reverse and in the discretion of the
herein named attorneys and proxies or their substitutes with respect to any other matters as may properly come before the 2024 Annual
Meeting that are unknown to ETFS Capital Limited (together with the other participants in its solicitation, &ldquo;ETFS&rdquo;) a reasonable
time before this solicitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Each of the proposals included
on this <B>GOLD</B> proxy card have been proposed by the Company. None of the proposals included on this <B>GOLD </B>proxy card are conditioned
on the approval of any other proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>STOCKHOLDERS ARE ADVISED
THAT THE COMPANY NOMINEES ARE NOT THE NOMINEES OF ETFS. BECAUSE THE COMPANY NOMINEES ARE NOT ETFS&rsquo; NOMINEES, THEY ARE NOT PARTICIPANTS
IN THIS SOLICITATION.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>THIS PROXY WILL BE VOTED
AS DIRECTED. IF NO DIRECTION IS INDICATED WITH RESPECT TO THE PROPOSALS ON THE REVERSE, THIS PROXY WILL BE VOTED &ldquo;AGAINST&rdquo;
THE ELECTION OF EACH OF [__], [__] AND [__] AND &ldquo;FOR&rdquo; THE ELECTION OF THE REMAINING COMPANY NOMINEES, &ldquo;FOR&rdquo; PROPOSAL
2, &ldquo;AGAINST&rdquo; PROPOSAL 3, &ldquo;ONE YEAR&rdquo; ON PROPOSAL 4, AND &ldquo;AGAINST&rdquo; PROPOSAL 5.</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">This Proxy will be valid
until the completion of the 2024 Annual Meeting. This Proxy will only be valid in connection with ETFS&rsquo; solicitation of proxies
for the 2024 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>IMPORTANT: PLEASE SIGN, DATE AND MAIL THIS
PROXY CARD PROMPTLY!<BR>
<BR>
CONTINUED AND TO BE SIGNED ON REVERSE SIDE</B></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left"><B>GOLD </B>PROXY CARD<BR>
 &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>[X] Please mark vote as in this example</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>etfs </B></FONT><B>STRONGLY
RECOMMENDS THAT STOCKHOLDERS VOTE &ldquo;AGAINST&rdquo; WITH RESPECT TO THE ELECTION OF [__], [__] AND [__] AND MAKES NO RECOMMENDATION
WITH RESPECT TO THE ELECTION OF THE COMPANY&rsquo;S OTHER NOMINEES. ETFS MAKES NO RECOMMENDATION WITH RESPECT TO PROPOSALS 2, 3, 4 AND
5.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4.5pt"></TD><TD STYLE="width: 18pt">1.</TD><TD STYLE="text-align: justify">Election of Directors to hold office until the 2025 annual meeting of stockholders.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 52%; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="width: 24%; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><B>AGAINST</B></TD>
    <TD STYLE="width: 24%; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ABSTAIN</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 35.1pt; text-indent: -0.25in"><B>1.&#9;[____]</B></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 35.1pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 35.1pt; text-indent: -0.25in"><B>2.&#9;[____]</B></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 35.1pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 35.1pt; text-indent: -0.25in"><B>3.&#9;[____]</B></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 35.1pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 35.1pt; text-indent: -0.25in"><B>4.&#9;All Other Company Nominees</B></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 31%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt; text-transform: uppercase">FOR ALL OTHER COMPANY NOMINEES</FONT></TD>
    <TD STYLE="width: 31%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">ABSTAIN ON ALL OTHER COMPANY NOMINEES</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P></TD>
    <TD STYLE="width: 38%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">FOR ALL OTHER COMPANY NOMINEES, EXCEPT NOMINEE(S) WRITTEN BELOW<SUP>*</SUP></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 4.5pt">&nbsp;</P>
    <P STYLE="font: 10pt Wingdings; margin: 0; text-align: center; text-indent: 4.5pt">&#168;</P></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 4.5pt">&nbsp;</P>
    <P STYLE="font: 10pt Wingdings; margin: 0; text-align: center; text-indent: 4.5pt">&#168;</P></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 4.5pt">&nbsp;</P>
    <P STYLE="font: 10pt Wingdings; margin: 0; text-align: center; text-indent: 4.5pt">&#168;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 4.5pt">_____________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 4.5pt">_____________</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">*Note: If you mark the &ldquo;FOR ALL OTHER COMPANY
NOMINEES, EXCEPT NOMINEE(S) WRITTEN BELOW&rdquo; box, your shares will be voted &ldquo;ABSTAIN&rdquo; on any such nominee(s) written in
the line(s) below this box and &ldquo;FOR&rdquo; the remaining nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">To vote on the Company&rsquo;s proposal to ratify the appointment of Ernst &amp; Young LLP as the Company&rsquo;s
independent registered public accounting firm for the fiscal year ending December 31, 2024.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 25%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 25%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT> FOR</TD>
    <TD STYLE="vertical-align: bottom; width: 25%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT> AGAINST</TD>
    <TD STYLE="vertical-align: bottom; width: 25%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT> ABSTAIN</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">To vote on the Company&rsquo;s advisory resolution to approve the compensation of the Company&rsquo;s
named executive officers.</TD></TR></TABLE>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 25%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 25%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT> FOR</TD>
    <TD STYLE="vertical-align: bottom; width: 25%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT> AGAINST</TD>
    <TD STYLE="vertical-align: bottom; width: 25%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT> ABSTAIN</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="line-height: 107%">4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="line-height: 107%">To vote </FONT>on the non-binding, advisory proposal on the frequency
of future advisory votes to approve the compensation of the Company&rsquo;s named executive officers.</TD></TR></TABLE>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center; width: 25%"><FONT STYLE="font-family: Wingdings; line-height: 107%">&#168;</FONT> <FONT STYLE="line-height: 107%">1 YEAR</FONT></TD>
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><FONT STYLE="font-family: Wingdings; line-height: 107%">&#168;</FONT> <FONT STYLE="line-height: 107%">2 YEARS</FONT></TD>
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><FONT STYLE="font-family: Wingdings; line-height: 107%">&#168;</FONT> <FONT STYLE="line-height: 107%">3 YEARS</FONT></TD>
    <TD STYLE="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%"><FONT STYLE="font-family: Wingdings; line-height: 107%">&#168;</FONT> <FONT STYLE="line-height: 107%">ABSTAIN</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="margin-top: 0; margin-bottom: 0"><B>GOLD </B>PROXY CARD</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">5.</TD><TD STYLE="text-align: justify">To vote on the Company&rsquo;s proposal to ratify the approval by the Company&rsquo;s Board of Directors
of the extension of the Stockholder Rights Agreement, dated March 17, 2023, as amended, by and between the Company and Continental Stock
Transfer &amp; Trust Company.</TD></TR></TABLE>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 25%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 25%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT> FOR</TD>
    <TD STYLE="vertical-align: bottom; width: 25%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT> AGAINST</TD>
    <TD STYLE="vertical-align: bottom; width: 25%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT> ABSTAIN</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">DATED: ____________________________<BR>
<BR>
____________________________________<BR>
(Signature)<BR>
<BR>
____________________________________<BR>
(Signature, if held jointly)<BR>
<BR>
____________________________________<BR>
(Title)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">WHEN SHARES ARE HELD JOINTLY, JOINT OWNERS
SHOULD EACH SIGN. EXECUTORS, ADMINISTRATORS, TRUSTEES, ETC., SHOULD INDICATE THE CAPACITY IN WHICH SIGNING. PLEASE SIGN EXACTLY AS NAME
APPEARS ON THIS PROXY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !3 3T# 2(  A$! Q$!_\0
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MX/3W/2O>/B!JFJ:1X3N;C1+:::\)"J8DW&,=VQ]/YUYOI'QYNH(?)US2EN'
MP9(6V$_53Q0!1M/C?JRS)'K6E65W"K LNPHX]QG(S^%>V:'K-KX@T>WU*Q8F
M"==P!ZJ>X/N#7SMX]\90>.M0L_[/T<6SQY7*C=+*3C@X';''UKV_X;:'<^'O
M!%C9WJE+@[I70]4+'.* .JJIJFI6^CZ9<7]X^RWMT+N1UP*MUS_CO1I]?\&:
ME86G-Q)'F-<XW$'./QQ0!Y(_Q9\0:IJLD/A31X(/-<OY<5OYLLGJ6QWJAXP\
M8^*K[P^^E^*M'\KS'5XIWMVB9"#V[<C(JAX"\9O\/M8O/MFG-*)5$<J$[)$(
M/O\ RK7\;_$N]\;:)/9Z?I+0Z=$5DN)6^=ASQR.%Y(H W_V?_P#CWUG_ 'H_
MY&O8Z\;_ &?W7R]93(W9C./;FO9* "OGSXZ_\CQ!_P!>:?\ H35]!U\^?'7_
M )'B#_KS3_T)J /6_ NBZ=:^"=,2*SA E@663<@)9B,DG/6NGK&\&_\ (FZ1
M_P!>D?\ Z#6U0 5Y[\3?B%:>%A#IZ64-]?R 3!)AF.(9X8CN>N*]!KP7XX^'
M[R'Q(FLK$[V=Q$L9D R$=>,'TR,?K0!+8_$/XCWT(O+/3&GM.H,=B2F/J.U<
M#XEU>77?$L^H7%FEI/,R^;$H( 8  G!YYKTG2OCK%8Z%;VLFBLUS!$(P8Y0L
M9P, XQD?2O.?%6HZAJWB274=6MOLMQ<[91'L*@(1\O!YZ=Z /JNT_P"/.#_K
MFO\ *IJ@L762PMW0@JT2D$=Q@5/0 E?-/@\_\7@M?^PA)_-J^EZ^6YKJZ\&?
M$B2[N;8F6TO6D,3'&]23T/N#UH ^HZ6N0\!^/HO'*7K1V36AMF4;6DWE@<\]
M!Z5U] #)7,<3N!N*J2!ZU\O>&;9/$7Q)M8]3_>)<WI:8-_'R3@_7&*^HZ^<O
MB!X2U+P3XJ;5=/2063S^?;W"#(B;.=I]"#^8H ^B6MX6MS;M$AA*[?+*C;CT
MQZ5\PZC;KX<^)\D.FMM2UU%?*QV&X''ZXKLF^/EZ=*\M=)A%_MQYWF'9GUVX
M_3-9'PU\'ZAXK\4IK6H))]BAF^T2S./]=)G( ]>>M 'T.#D TM%% 'C_ .T!
M=2+8Z-:KN$3R22-Z$@*!^6X_G6C\#-*M8?"DVHJB&[N)V1WQR%7&!^N:V?BI
MX0F\6>&0+)=]]9N984_OC&&7ZGC\J\<\'>/]5\ 37-FUJ)8';,EM-E2CCC(]
M#0!W7Q]M+==-TNZ6&,7#3,C2A?F*[<X)K;^!_P#R(!_Z^Y/Y+7DWC;QMK/C2
M&"XO+46^G12%85C4[=^.?F/4XKUGX'_\B ?^ON3^2T >B4E+36&Y2OJ,4 >-
M>,_BZ]OXAEM/#FGVTEQ 3 ;R6/>[$'H@],_G5*;Q[X_M;*636M#:;3Y8RDGF
MV;(NTC'4?UKD[J&_^'GQ!6XNK3S&M;@RQB3[LR$G!!^A_ UW6H?&V?6;4Z?H
M.ARF]N08U\QO,QD8X4#F@#C_ (1D'XDZ>0, B3C_ ( :^EJ^:/A.WE?$O3Q+
M\K9D7!]=IXKZ7H 2LJ_\+:'JDADOM)LYI"<EVA&X_4]36M10!EZ;X9T;2)/,
MT[3+2WD_OI$ WY]:TZ6B@ I*6B@#.O\ P_I.J2^;?Z99W$G]^6%6;\\9J6'2
M=/M[-K2"QM8[9OO1+$H0_48P:N44 5K73K.Q9FM+2W@+##&*)5S]<"K-%% !
M52YTNPO9!)=65M.X&-TL2L<>F2*MT4 -CC2*-4C1411A548 'L*=110 E-EA
MCN(FBFC22-QAD=001[@T^B@#)A\*Z#;SB:'1M/24'(9;=<@^W'%6[C2M/O)?
M,NK&UFDQC=)"K''U(JW10 U$6-%1%"JHP% P *=124 +67JWAK1]=*G5-.MK
MIE& TB?,!]>M:E% %#2M"TS1(VCTNQ@M5?[WE( 6^I[U?HHH *9+#'/$T4R+
M)&PPRN,@CW%/HH PQX*\.+<>>-$L/,SG/D+C\NE;,<:11JD:JB*,!5& !]*?
M10 4444 8WBOQ);>$] GU.[5G"?*B*.7<]!GM]:\^M/BKX-UZ)'\1:3'%=C&
MXR6ZS+^#8SBO5;BWANH'AN(DEB<;61U!##W!KB[_ .#OA*^F,BV<ML3R1!*5
M7\CG'X4 >7?$[QSI?B:"PTW0K4Q65HQ?=Y8C!)&,*HZ"O5_A1HMQHG@.TBNT
M*33NUP4/50W0'\ #^-2Z)\+_  OH5PEQ;V'G3H<K)<,9"I]0.F?PKK: %HHH
MH JWVF66IQ"._M+>Y0<A9HPX'TS45AH6EZ4Y?3].M+9SU:*%5)_$"K]% %*/
M1].AF$T6GVB2@Y#K"H8'USBKM%% !1110 4444 %%%% !1110 445GRZ]IL,
MK1R7D:NAPP/8U,I1C\3L5&$I_"KFA169_P )%I7_ #_1?G6A%*DT2R1L&1QE
M2.XHC.,OA=QRISA\2:'9HR/6O)/B#<31^+YUCFE1?*CX5R!TKFOM=S_S\S_]
M_&_QJ'5L[6/7HY.ZM.,^?=7V_P""?0&1ZT9'K7S_ /:[G_GYG_[^-_C1]KN?
M^?F?_OXW^-+VWD:?V&_Y_P /^"?0&1ZT9'K7S_\ :[G_ )^9_P#OXW^-'VNY
M_P"?F?\ [^-_C1[;R#^PW_/^'_!/H#->0?&OQ%J^B:II::7J-S:))"Y=89"H
M8[AR<5W?@!VD\)6S2,SL6;ECD]:\[^-UJM]XK\.VK,56<&,L.P+@9_6M4[JY
MXM:G[.I*'9V///\ A/O%/_0?U'_O^U'_  GWBG_H/ZC_ -_VK8U3P+;6L=PR
M#5+06]PD(:^A55G#/L^0CO\ Q?2EU?P!%;)>BUCU2"2WF6*-[Z)4CN27"@(P
M[\Y^@-,S,;_A/O%/_0?U'_O^U'_"?>*?^@_J/_?]JN'PQI$^HW.C6>H7+ZK;
MJX#O$!#+(@)9!W'0X)ZXIC^%;-- &O?;)3IC1[%&T>;]I[QGMCON]/>@"M_P
MGWBG_H/ZC_W_ &H_X3[Q3_T']1_[_M4U]X8L;/1VU@:AYEC/&!9J /->;^)&
M'8+SD]\C'6H8-'TNSTBRO=:N;H-?%FABM54E(U;:68GW!P!Z=: #_A/O%/\
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8% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !3 3T# 2(  A$! Q$!_\0
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MOX;T*ZU2Z!:.!<A!U<G@ ?4UXG_PM'QUXEOI!H,.Q5Y\JVMA)M'N6!_I0!]
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M.#T]STKWCX@:IJFD>$[F?0[:::\)"J8DW&,=VQ]/YUYOI'QYNH(?)US2EN'
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MZ\T_]":@#UOP+HNG6O@G3$BLX0)8%DDW("68C))SUKIZQO!O_(FZ1_UZ1_\
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M=U:<9\^ZOM_P3Z R/6C(]:^?_M=S_P _,_\ W\;_ !H^UW/_ #\S_P#?QO\
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M&5EOIA<,"#^[D#$AD_NGDCZ5UG_"D/%7_3C_ -__ /ZU'_"D/%7_ $X_]_\
M_P"M5&!S\_C.YE\^9+&RBU"Y0QS7L<9$C C#$<X!(ZD#U]:A/BZ_:-X&6 V3
MVPMOLFS]TJCD,!V;/.[KFNF_X4AXJ_Z<?^__ /\ 6H_X4AXJ_P"G'_O_ /\
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%10!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !3 3T# 2(  A$! Q$!_\0
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M=N/TS61\-/!^H>*_%*:UJ"2?8H9OM$DSC_729R /7GK0!]#@Y -+110!X_\
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MNF\[SL'E0V[/3TS5R7Q-?S+J"R,K+?3"X8$']W(&)#)_=/)'TKK?^%'^*?\
MIQ_[_P#_ -:C_A1_BG_IQ_[_ /\ ]:J,#GI_&=S+Y\R6-E%J%RACFO8XR)&!
M&&(YP"1U('KZU ?%U^T;P,L!LWMA;?9-G[I5'(8#LV>=W7-=1_PH_P 4_P#3
MC_W_ /\ ZU'_  H_Q3_TX_\ ?_\ ^M0!P\VJ3SZ1;::P3R+:1Y4('S9?&<G_
M ("*O6/B5[?3HK&[L+._@@<O +A3F(GJ 01\I/.#75?\*/\ %/\ TX_]_P#_
M .M1_P */\4_]./_ '__ /K4 <S#XKE$4D%YI]C=VS3&=(9(RJQ,>NS:1@'
MXZ5#>>*-0OEO!*T:BZ:(G8NWRQ'G8J>@&:ZS_A1_BG_IQ_[_ /\ ]:C_ (4?
MXI_Z<?\ O_\ _6H YRY\9WNHWJW.J6UG?,+9;9A-%]Y5)(;(Y#9/44+XQN4F
MB$=E9K91V[6WV/83&R,=S9YSDGG.?2NC_P"%'^*?^G'_ +__ /UJ/^%'^*?^
MG'_O_P#_ %J .:/BZY6[ADBL[..VAMY+9+4(?+V/G?GG))R><U5_M]XKAY;2
MRM+4O ]NRQ*<%6&">2>:Z_\ X4?XI_Z<?^__ /\ 6H_X4?XI_P"G'_O_ /\
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>1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
